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ABSTRACT
REVERSIBLE GELATION OF GENETICALLY ENGINEERED
MACROMOLECULES
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Ph D
,
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Directed by: Professor David A. Tirrell
Genetic engineering of protein-based polymers offers distinct advantages over
conventional synthesis of polymers. Microorganisms can synthesize high molecular
weight materials, in relatively large quantities, that are inherently stereoregular,
monodisperse, and of controlled sequence. In addition, specific secondary and higher
order structures are determined by this protein sequence. As a result, scientists can
design polymers to have unique structural features found in natural protein materials and
functional properties that are inherent in certain peptide sequences.
For this reason, genetic engineering principles were used to create a set of
artificial genes that encode twelve macromolecules having both a-helical and disordered
coil protein sequences with the last amino acid being cysteine (cys) or tryptophan (trp).
Triblock copolymer sequences having coiled-coil protein ends, A or B, where A and B
represent a-helical acidic and basic leucine zipper proteins, separated by a water soluble
flexible spacer coil protein, C, where C represents [(AG)?PEG]n (n=10 or 28), showed
reversible physical gelation behavior. This behavior is believed to resuh from the
vii
aggregation of two or more helices that form physical crosslinks with the disordered coil
domain retaining solvent and preventing precipitation of the chain.
DitTusing wave spectroscopy was used to investigate the gelation behavior of
ACioAcys in buffer when environmental conditions such as pH, temperature, and
concentration were varied. The dynamic intensity autocorrelation flinction recorded
over time for 5% (w/v) ACioAcys showed that the protein behaved as a gel at pH 6.7-
8.0 and that the melting point was between 40 "C and 48 "C.
In addition to the triblock results, the incorporation of 5',5',5'-trifluoroleucine
(Tfl) in place of leucine (Leu) in the A and B blocks was accomplished by synthesizing
proteins in bacterial hosts auxotrophic for Leu. The substitution of Tfl for Leu in A and
B was confirmed by electrospray mass spectrometry. Amino acid analyses performed on
purified Tfl A and Tfl B populations suggested 66% and 38% levels of Tfl substitution,
respectively. Thermal denaturation temperatures measured by circular dichroism of the
Tfl containing helices were higher than those of the corresponding Leu containing helices
by 8 "C and 1 3 "C for A and B respectively.
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CHAPTER 1
INTRODUCTION
11 Model Biological Polymer Systems
Nature provides us with many unique material systems that are important in both
organization and ftinction. For instance, some chemical and mechanical properties found
in natural fibers such as wool and silk that are derived from animal origins, or those of
cotton, jute, and flax derived from vegetable origins have not yet been duplicated in
synthetic fibers. Wool, for example, contains a high content of certain nonpolar amino
acids such as glycine and proline which are thought to make woolen fabrics both
moisture removing and heat retaining materials (1,2). Silk contains certain amino acids
which impart both strength and toughness in fibers, whereas the amino acid sequences of
mammalian elastin fibers provide flexibility. These specific properties, along with many
others, are attractive from a materials standpoint, and syntheses of natural assemblies
would be a first step in elucidating the chemical compositions and conformations which
give rise to specific structures and functions in materials.
Repeating patterns of amino acids, as in fibrous proteins, are one group of
constituents in naturally occurring materials. One method of synthesizing these
polypeptides is by genetic engineering or recombinant DNA technology. This
technology utilizes the same machinery that naturally produces protein for the survival of
the host organism. The general process of making genetically synthesized materials
begins with inserting a chemically synthesized piece of DNA, which encodes a specific
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pattern of amino acids, into a circular cloning vector through a series of cutting and
ligating reactions. Once the proper DNA sequence is verified, this piece ofDNA is cut
from the cloning vector and inserted into an expression vector which allows for protein
production in a host microorganism such as E. coli. E. coli cells are then grown to some
optimal density and production of the protein is initiated. After an allotted amount of
time, the cells are lysed and the proteins removed for purification and characterization.
The advantages of this protein polymer technology (3) are that microorganisms can
synthesize high molecular weight materials, in relatively large quantities, that are
inherently stereoregular, monodisperse, and of controlled sequence.
The most important advantage of designing and synthesizing polymeric materials
by this biosynthetic route is the ability to control the structure of a material on
microscopic and macroscopic levels. It is rare that both stereoregularity and
monodispersity are achieved by conventional methods of polymerization such as step,
chain, ring-opening, or coordination methods. Biosynthetic polymers, on the other hand,
have both of these characteristics built in naturally and in many cases, the degree of
structural control extends to the secondary, tertiary, and quaternary levels. In turn, the
physical properties associated with these biomaterials can be developed on the bases of
shape, hydrophilic/hydrophobic character, and charge placement.
The design of structurally and fiinctionally interesting biological macromolecules
requires an understanding of protein structure and how it relates to amino acid sequence.
The different levels of structural complexity of a polypeptide in solution or in the solid
state are directly related to the chemical nature of both macromolecule and its
environment. Variables such as pH, temperature, and concentration will influence the
types of conformations that polypeptides adopt in solution. Favorable or unfavorable
solvent-polymer interactions will contribute to the overall dimensions of the polymer.
For instance, a good solvent results in expanded conformations from preferred segment-
solvent interactions and a poor solvent tends to force chains to contract to exclude
solvent and to aggregate and precipitate (4). The correlation between conformations
existing in natural polypeptides and their amino acid periodicity form the basis for
rational materials design.
Proteins are generally classified as either globular or fibrous and have various
conformations within each of these groups (5). Fibrous proteins, consist of repeated
sequences of amino acids which have short range order and in some cases, long range
three-dimensional order. The secondary structures of fibrous proteins are defined in
terms of bond geometry, electron delocalization, sequence symmetry, polar and/or ionic
bond character and hydrogen bonding propensity (6). The geometry of a polypeptide
backbone is described by angles (j);, T„ and coi, for Ni-Ci, C„i-Ci, and Ci-Nj,, bonds
respectively. Electron delocalization of the C-N bond directly influences the coi rotation
since the C-N bond distance in a peptide is 1 .32 A compared to 1 .47A for a normal C-N
bond (6). As a result, sterics and electron configuration will force six atoms in the
peptide chain to be planar and fixes co; at or near 0 "C or 1 80 "C; the latter being more
energetically preferred.
Fibrous proteins are formed from a repeated peptide sequence which in turn leads
to repeated (f), T, and co bond rotational sequences. On the other hand, globular proteins
will have very few peptide repeats or bond rotational symmetries. The (]), NK, and cd
angles of fibrous proteins therefore will depend on van der Waals radii or the overlap
potential of neighboring atoms, ionic or polar forces acting over longer distances than
the van der Waals interactions, and intrachain or interchain H-bonding that exists in
secondary or tertiary structures. Characteristic (j), ^, and co angles have been calculated
for known a-helical, P-turn, and random coil protein sequences (7).
The recombinant DNA process previously outlined is being used to synthesize
structurally and functionally unique copolymers to be described herein. Both a-helical
and random coil fibrous proteins are combined in one chain to impart both rigidity
through the "hard" helical segment and flexibility through the "soft" coiled segment. The
general design of the triblock copolymer is a helix-coil-helix motif where the helix
belongs to a special class of coiled-coil proteins, leucine zippers, and the random coil
sequence belongs to a class of repetitive alanylglycine proteins, [(AG)3PEG]n (n = 10,
28) (8, 9). The structural motif includes helical end blocks that will recognize and
associate with each other through interchain hydrophobic and electrostatic interactions
separated by random coil domains that will act as flexible water soluble spacers inserted
between these ends.
1.2 Molecular Recognition and Association of Engineered Macromolecules
The helical elements are unique because they can be classified as part of a group
of materials that spontaneously self-organize into well-defined supramolecular arrays
under a given set of conditions (10). A range of potential applications that exist for
molecular recognition of macromolecules include reversible gelling systems and
adhesives (11), thermoreversible networks (12, 13, 14), non-covalent fiber networks.
and recyclable materials. Natural self-assembling protein materials that have reversible
structural and physical properties given the appropriate pH, temperature, and solvent
conditions can be modeled and designed after naturally occurring proteins found in both
the body and the environment. For this reason, proteins modeled after a class of self-
assembling a-helices called coiled-coils are being used in this research.
1-2.1 Coiled-Coil and Leucine Zipper Proteins
Polypeptides such as keratin and myosin are known to adopt a-helical
conformations which were originally thought to pack into parallel orientations with
straight axes (15). Not long after this proposal, Pauling and Corey observed that the
actual packing of a-keratin was a long range phenomenon and that the axes of individual
helices pursued a helical course to form multistranded cables (16). The origin of
deformation resulted from what was believed to be repeating sequences of amino acids;
every fourth and seventh amino acid was repeated. At the same time, Crick (17)
proposed that very long chains of amino acids could indeed form what was termed
"coiled-coils". It was in this work (18) that the calculations of the predicted X-ray
diffraction pattern for double and triple stranded ropes were generated. More
importantly though was that the calculated equatorial and meridional reflection were
very similar to the experimental results of MacArthur (19) and Perutz (20). The results
showed meridional arcs at spacings of approximately 5. 1 A and 1.5 A and a group of
reflections on and near the equator at spacings approximately 10.5 A.
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These investigations led to the initial studies of how, why and when a-helices
recognize each other and pack into a favorable conformational state. It was not until
1991 that Alber and co-workers (21) determined the X-ray structure of a 33-residue
leucine zipper portion of the yeast transcription factor, GCN4, a special type of coiled
coil protein that belongs to a class of transcription factors that regulate the expression of
many different genes in both simple and complex organisms. Since 1991, others have
determined high resolution X-ray crystal structures of similar two stranded coiled-coils
(22, 23, 24).
Prior to solving the crystal structures of this family of eukaryotic transcription
factors referred to as the basic-region-leucine-zipper (bZIP motif), other structural
features of the leucine zipper had been determined. The first amino acid sequence of a
coiled-coil, tropomyosin, indicated that the stabilization of the super coiled helices
resulted from a 3-4 hydrophobic repeat (25, 26). It was suggested that a seven amino
acid repeat, (a h cc/efg)„ where a and d amino acids were hydrophobic residues,
defined a coiled-coil. It was Hodges et al. who synthesized and characterized the first
synthetic coiled-coil analog of tropomyosin (27). While investigating short coiled-coil
domains ofDNA binding proteins, Landshulz et al. named this class of proteins "leucine
zippers" for what was believed to be leucine sidechains interdigitating like the teeth of a
zipper at the d position on adjacent helices (28). However, it was later confirmed by the
X-ray crystallographic data previously mentioned that the leucine sidechains pack in a
side-to-side arrangement on adjacent chains.
In addition to the hydrophobic core, which is formed by the side-to-side packing
of the a and d residues that are aligned on the complementary faces of two I2 a-helices.
it has been shown that the formation of coiled-coils is llirther modulated by interactions
between regularly spaced charged groups at specific positions in the general heptad
repeat (29). The stabilization of the super coiled helices is enhanced or diminished by
positioning attractive or repulsive charged groups at e and g positions (30). It is then
possible to design polypeptides that have the propensity to form parallel or antiparallel
interchain attractive coiled-coils based on charge-charge interactions at the e and g
positions on adjacent helices (3 1).
Parallel and antiparallel arrangements oftwo leucine zippers are best illustrated
by considering the general positions of residues that are in proximity to each other. In a
coiled-coil structure, positions a and d of two I2 helices (two turns per seven amino
acids with a pitch of 5.2 A) are associated at the interface and intertwine to form a super
coiled structure with a slight left-handed twist. The frequency of finding hydrophobic
residues, mainly leucines, at these two positions in coiled-coils has been calculated by
Lupas and co-workers (32). A general representation of parallel and anti-parallel
dimerizations of two a-helical leucine zippers is shown in Figure \ 1 where one chain is
denoted by a general heptad repeat {ahcclefg\ and the other by (a' h' c' d' e '/' g %.
In addition to the dimer state, leucine zippers are also known to form trimeric (33, 34,
35, 36, 37, 38) and tetrameric aggregates (39, 40, 41). These higher order aggregate
states are referred to as multiple-helix bundles instead of coiled-coils. This distinction
has been made because of the difference in packing between hydrophobic faces; coiled-
coils contain a narrow hydrophobic surface whereas multiple helix bundles have a wide
surface. The latter surface involves additional hydrophobes in the packing arrangement.
It has been suggested that the conformation of the core amino acid side chains determine
whether a two-, three-, and four-stranded oligomerization state will predominate (42,
43).
1-2 .2 Original Design of Proteins Al and Rl
A set of coiled-coil proteins, AI and Bl, designed by McGrath el al. (44) is
being used as associating a-helical proteins (Figure 1.2). Both Al and Bl proteins
contain a 42 amino acid sequence (six internal heptad repeats, ahcdefg) which
constitutes the coiled-coil region. The choice of residues at positions a and d was based
on the a / 1/ residue patterns see in the J//// oncogene product (45), which forms a weakly
stabilized homodimer. An algorithm developed by Lupas el al. (32), which identifies the
most probable amino acids at positions a-^, was used to select residues occupying c,
and/ positions in coiled-coils. Residues that would increase the solubility of the coiled-
coil complex in water were chosen first for these positions. Acidic or basic groups,
glutamic acid and lysine, respectively, were placed at the e and g positions to provide
intermolecular attraction or repulsion between chains. The placement of oppositely
charged groups at e and g positions in Al and Bl proteins was designed to maximize
heterodimer formation over either homodimer when solutions equimolar in A 1 and B
1
are mixed. The underlined regions of the Helix in Figure 1 .2 emphasize this charge
pattern at positions e and g. Helical wheels representing parallel and antiparallel
arrangements of Al and Bl homodimers and heterodimers are shown in Figures 1.3 and
1.4.
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As stated previously, the stabilization of coiled-coils can be modulated by both
intra- and interhelical electrostatic interactions (29). Eleven nearest neighbor intrachain
electrostatic interactions exist on both Al and Bl helices. In addition, ten elg interchain
interactions exist for the dimerization of either Al or Bl proteins. The intrachain
interactions are described and listed in Figure 1.5. Attractive or repulsive interactions
along the helix will significantly affect the stability of an individual a-helix as well as
state of association of many helices. It has been suggested that both intra- and
interhelical interactions are cooperative processes in coiled-coil formation (46).
1 2.3 Evidence for Helical Interactions of Coiled-Coil Proteins
Prior to the construction of new DNA encoding the Al and Bl helical elements,
the biological syntheses of Al and Bl proteins were done initially to test the feasibility of
forming a-helical leucine zipper macromolecules and to see if they would form
homodimer and/or heterodimer coiled-coils in solution. The resulting studies have
focused on determining the association characteristics of Al-Al, Bl-Bl, Al-Bl
mixtures in solution when environmental factors such as temperature, solvent, and pH
are varied.
1.2.3.1 Physical Properties
The physical properties of Al and Bl complexes are listed in Tables 1.1 and 1.2.
The charge pattern at the e and g positions along the heptad repeat distinguishes A
I
9
from B
1
;
the polar charged groups at these positions determine whether the protein
chain is largely acidic or largely basic, Complexation studies for both proteins were
performed with sedimentation equilibrium centrifligation analysis (47, 48). These data
suggest that homodimer complexes exhibit a concentration-dependent dimer-tetramer
equilibrium in solution. Values of Kj are significantly different for Al (K,, = 76 ^M) and
for Bl (Kd - 123 (iM). in both Al and Bl, tetramer to octamer equilibria constants
were observed at concentrations greater than 200 |.iIVl. The mixture of Al-Bl gave
ambiguous results which are not included in the table.
Although Al and Bl proteins were originally designed to form parallel coiled-
coils, both parallel and antiparallel alignments have to be considered here because the
exact orientation is not known. Only one orientation can exist for a particular coiled-coil
and therefore the dimerization is either parallel or antiparallel (46), The orientation can
be determined with circular dichroism by monitoring the thermal denaturation at 222 nm
as a function of concentration for helical sequences containing one cysteine end and for
those that do not. O'Shea el al. (29) have shown that solutions of GCN4-pl containing
helices that lack cysteine end-groups exhibit concentration-dependent thermal transitions.
The same solutions show no concentration-dependent thermal transitions over the
concentration range of 0-35 |aM for sequences that form parallel homodimers by N-
termini linking. A concentration dependence would arise if the molecules did not favor
parallel orientations and were free to bind to other helices. Similar results were obtained
for parallel orientations of Fos, Jun, and Fos/Jun peptides at concentrations of 1-20 |aM
(49) and for favorable antiparallel arrangements of coiled coil stem loop CCSL peptide at
concentrations of 0,1-1000 ).iM (50), Both Al and Bl proteins have been modified to
0
include a single cysteine at the C-terminus for probing the orientation of Al and Bl.
The synthesis of these molecules is described in Chapter 2.
1.2.3.2 Helix Content
Circular dichroism spectroscopy (CD) was used to study the secondary structure
formation and energetics of interactions between Al and Bl protein chains in buffered
aqueous solutions. The a-helical conformations of these proteins give rise to a
characteristic CD spectrum. The three amide transition CD bands of interest are
-[Q]222
(n->7t*),
-[e]2()8 (ti^tc*, parallel), and +[e],9o (ti^tc*, perpendicular) where [G]x is the
molar ellipticity measured at x wavelength in nm. The % helix content can be calculated
by the method developed by Chen et al. (51) where eight basis spectra of helical proteins
were used to determine 1 00% helix content of a protein x amino acids in length at any
wavelength in the 185-250 nm regime. Estimation of helicity (% helix) is calculated by
the following equation:
% helix = [e]222 / [e]n,ax { 1 }
where [0]max = -39500 [l-(2.57/n)] (deg cm^ dmol"') and
where n = 42 for A 1 and B 1 , then
[0]max = -37082.97 (deg cm^ dmol"').
In the design of the Al and B 1 proteins, 42 out of 74 amino acids (57 %) comprise the
a-helical leucine zipper region. The molar ellipticities at 222 nm of Al and Bl measured
II
at 25''C in 50 mM sodium phosphate, 100 mM NaCl pH 7.4 at a total protein
concentration of 3 nM were reported as -24390 and -24669 respectively (52). These
data correspond to helix contents of 65.8% for Al and 66.5% for Bl
1 2.3.3 Thermodynamic Analysis
Thermal and urea denaturation studies were done with 3 iiM solutions of Al, Bl,
and Al-B 1 complexes and the results are shown in Figures 1 .6 and 1 .7 (52). The
temperature curves show that the thermal transition temperature, T^, from a folded to an
unfolded state is higher for the Al-Bl mixture than either of the Al-Al or Bl-Bl
solutions. These results are similar to the urea denaturation profiles which show a higher
[urea]'/, (transition where 50% of the helix is unfolded at 20X) for the unfolding process
of Al-Bl than for the Al-Al and Bl-Bl. This means that at pH 7.4 the heterodimer
complexes are more stable than either of the homodimer complexes. Table 1 . 1 compares
the data collected and calculated from these curves for Al-Al, Bl-Bl, and Al-Bl
interactions. These data show that the transition temperature for the heterodimer
complex is higher than that of either homodimer solution. In addition to this, the free
energy of unfolding, AGu, and the difference in the free energies of unfolding, AAGu, also
increase upon mixing of equimolar solutions of Al and Bl . Note that AGu is obtained
from plotting lnKd,u (equilibrium constant for dissociation of dimer to monomers) against
[denaturant] and extrapolating back to zero denaturant concentration (53, 54) whereas
AAGu can be determined by comparing free energy values of proteins that are calculated
when 50% of the protein has unfolded in the presence of denaturant (55, 56). The latter
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method minimizes any errors that are introduced in the measurement of the slope by
extrapolation back to zero.
If the arrangement (parallel or antiparallel) is known then it is possible to
calculate the Kcal/mole stabilization for each attractive interaction going from a
homodimer complex to a heterodimer complex. This has been calculated by many
groups (45, 56, 57) and the stabilization values range from 0. 16-0.20 Kcal/mole per ionic
interaction. The exact orientation of Al and Bl needs to be determined prior to this
calculation as the number of attractive interactions differs in the parallel and antiparallel
orientations for the homodimer as well as for the heterodimer complexes (refer to Table
1.2).
Thermal denaturation curves as a function ofpH were recorded with 1 2 ^iM
solutions of Al, Bl, and the Al-Bl mixture (Figures 1.8, 1.9, 1.10). At lower pH
values, the thermal transition occurs at higher temperatures for Al. This might be
expected since A 1 chains contain carboxylic acid groups at the e and g positions in the
heptad repeat and lower pH values would promote the formation of coiled coils as the
sidechains remain protonated. At higher pH values, the negatively charged carboxylate
groups might cause interchain electrostatic repulsion and reduce the stability of the
coiled coil structure. The opposite trend is observed for Bl, and is consistent with this
argument because Bl chains contain basic lysine sidechains at the e and ^ positions. The
data for the equimolar mixture of Al and Bl shows that at every pH the transition
shifted to a higher temperature.
Thermal reversibility studies were carried out with A 1, Bl, and Al-Bl solutions
(12 \M) at pH 7,2 with 30 minute equilibration times between scans. CD spectra were
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recorded for each solution after one thermal cycling. A helical structure exists for all
three protein solutions at OT as shown in Figures 1.11-1.13. However, scans of the
solutions at temperatures above the transition temperature for Al and above but close to
the transition temperatures for Bl and Al-Bl indicate that a more randomly coiled
structure exists in solution. The reduction of [9] at 222 nm after thermal cycling was
found to be less than 5% for each protein. The interpretation is that the transition from
folded to unfolded states are thermally reversible for A 1, Bl, and Al-Bl solutions.
Table 1.1 Thermodynamic analysis of Al-Al, Bl-Bl, and Al-Bl interactions.
Dimer
Complex
T„ in PBS
(xy
[Urea]
(M)*
slope
m^
AGu
(Kcal/moley
AAGu
(Kcal/mole)
Al-Al 58.3 3.57 -1.295 11.54 0.00
Bl-Bl 75.5 3.66 -1.512 12.55 0.13
Al-Bl 86.3 5.76 -1.165 13.76 2.75
" Tn, = temperature at which 50% of the helix is unfolded in 50 niM sodium phosphate, 100
mM NaCl. pH 7.4.
* Concentration of urea at which 50% of the helix is unfolded at 20°C.
' AGu = molar free energy of folding calculated from the urea denaturation profiles.
1.3 Summary
The reversibilty of the helical folding of Al and Bl proteins with pH and
temperature forms the basis for the helical-random-helical block copolymer design. The
idea is to create an architecture where the non-covalent crosslinks, helical ends, are
precisely controlled with pH and temperature. To be described herein is the genetic
14
construction as well as the protein synthesis of the triblock copolymers, the reversible
gelation studies of one of the triblocks synthesized, and the modifications of the original
Al and Bl proteins at the hydrophobic interface.
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Helical wheel representation of coiled-coil structure, (a) Representation
of a parallel coiled-coil viewed down the helical axes from the NH2-
termini and (b) representation of an antiparallel coiled-coil viewed down
the helical axes from the NH2- and the COOH-termini. Interhelical
hydrophobic interactions are present between the a, a\ d, and d' groups
whereas the e, e', g, and g' form the electrostatic interhehcal
interactions.
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N' MRGSHHHHHHGSMA -
-
IGDLNNTSGIRRPAAKLN C
- SGDLENEVAQLEREVRSLEDEAAELEQKVSRLKNEffiDLKAE - Al
Helix = SGDLKNKVAQLpiKWSLKX)KAAELKQEVSRLENEIEDLKAK = Bl
Figure 1 .2 Amino acid sequences for recombinant leucine zipper proteins,
Al and Bl
.
Charge patterns in the e and g positions of the Helix
heptad repeat, {a b c d efg)^, axQ underlined and eight leucine
positions in each chain are bolded. Abbreviations for the amino
acids are : A, Ala; C, Cys; D, Asp; E, Glu; F, Phe; G, Gly; H, His;
I, He; K, Lys; L, Leu; M, Met; N, Asn; P, Pro; Q, Gin; R, Arg;
S, Ser; T, Thr; V, Val; and W, Trp.
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Figure 1.3 (a) Parallel coiled-coil of Al homdimer (b) parallel coiled-coil of Bl
homodimer and (c) parallel coiled-coil of Al-Bl heterodimer.
18
^ V KG
Figure 1.4 (a) Antiparallel coiled-coil of Al homodimer (b) antiparallel coiled-coil of
Bl homodimer and (c) antiparallel coiled-coil of Al-Bl heterodimer.
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(a)
(b)
/ to i+4 i to /+3 /• to /+4 / to /'+3bf be eg cf
R D R E/K D E/K none
E E/K E E/K
R E/K
D E/K
/ to 7+4
e b
E/K R
E/K E
/' to /+4
f c
D E
/ to 7+3
f b
R R
/ to /'+4
g- d
none
/ to /+3
g c
E/K E
E/K R
E/K D
Figure 1.5 Intrachain electrostatic interactions, (a) Parallel coiled-coil
positions a-g denoted / to /+6 and / * to / '+6. (b) Intrachain electrostatic
interactions of positions b, c, e, and/where / represents the position
being considered along the helix.
r
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Temperature ("C)
Figure 1 6 Thermal melting profiles ofA 1 -A 1 , B 1 -B 1 , A 1 -B 1 dimers. The fraction
of unfolded peptide was determined by monitoring CD spectra at 222 nm
(3 [iM protein in 50 mM NaH2P04, 100 mM NaCl, pH 7.4).
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Figure 1.7 Urea denaturation profiles of A 1 -A 1 , B 1 -B 1 , and A I -B 1 dimers, The
fraction of unfolded peptide was determined by monitoring CD spectra at
222 nm as a function of [urea] (0-9.5 M) (3 mM protein concentration
in 50 mM NaH2P04, 100 mM NaCl, pH 7.4).
23
0[6]222 111)1
-5000
10000 -
-15000 -
pll 10.1 pIIS. PHTI •pn2.1
-20000 - M
25000
•••
•A*
•30000
0
n r
10 20 5030 40 60
Temperature ("C)
70
I
80 90 100
Figure 1
.8 Thermal denaturation curves recorded at 222 nm for A 1 ( 1 2 luM protein
in 10 mM NaH2P04) at pH2.1, 7.1, 8.1, and 10.1.
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Figure 1 .9 Thermal denaturation curves recorded at 222 nm for B 1 ( 1 2 i^M protein
in 1 0 rtiM NaH2P04) at pH 2. 1 , 4. 1 , 7. 1 , and 10. 1
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Figure 1.10 Thermal denaturation curves recorded at 222 nm for equimolar Al -B
1
(12 |LiM protein in 10 mM NaH2P04) at pH 2.1, 4.1, 8.1, and 10.1.
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Figure 1.11 Molar ellipticity, [0], as a function of wavelength recorded for Al
(12 i^M protein in 10 mM NaH2P04, pH 7.2) at temperatures of 0 and
75 X.
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Figure 1.12 Molar ellipticity, [9], as a function of wavelength recorded for Bl
(12 |iM protein in 10 mM NaH2P04, pH 7.2) at temperatures of 0 and
90 "C.
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Figure 1.13 Molar ellipticity, [0], as a function of wavelength recorded for
equimolar Al-Bl (12 i^M protein in 10 mM NaH2P04, pH 7.2) at
temperatures of 0 and 90 "C.
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CHAPTER 2
SYNTHESIS OF GENETICALLY ENGINEERED MONODISPERSE BLOCKCOPOLYMERS WITH HELIX-COIL-HELIX DOMAINS
2.1 Introduction and Objectives
Genetic engineering principles were used to create a new class of artificial
proteins that combine the unique properties of coiled-coil leucine zipper proteins with
those of a flexible water soluble random coil protein, [(AG)3PEG]n (n = 10 and 28).
Triblock proteins having a-helical end blocks separated by random coil domains are
being synthesized for potential use as reversible three-dimensional networks where
physical aggregates oftwo or more helical chains form the junction points and the
random coil domains control swelling of the gel. Reported herein are the details of the
genetic design and DNA cloning strategy for assembling the helix-coil-helix domains as
well as the corresponding bacterial syntheses and characterization data of these
macromolecules.
2.1.1 Design of End-Associated Polymers
Protein engineering of polymers provides an efficient and controlled synthetic
route to the production of de novo protein-based materials that have chemical and
mechanical properties that are similar to or exceed those of natural materials. Our
research interests have involved the synthesis of polymers with precisely controlled
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architectures (1,2) and with unusual chemical and biological function (3, 4). It is our
goal to design and create entirely new polymeric systems where precise molecular
weight, stereoregularity, sequence, and function are concurrently controlled. To this
end, monodisperse triblock copolymers with helix-coil-helix domains were designed and
synthesized by genetic engineering principles for the study of reversible physical gelation
processes. Both structural and functional elements are being combined through a-helical
ends, coiled-coils, and random coil domains, [(AG)3PEG]n (n = 10, 28).
The genetic strategy for the synthesis of materials that contain naturally occurring
helical protein ends (designated A and B) separated by an artificial random coil protein
(C) is described herein. The end blocks are representative of a class of coiled-coil
proteins called leucine zippers that are known to associate through interchain
hydrophobic and electrostatic interactions (5). Association of coiled-coil leucine zipper
proteins can produce dimers, trimers, tetramers, and higher order aggregates, depending
on the details of the sequence (6).
The a-helix in the triblock design considered here is a 42 amino acid leucine
zipper protein that forms stable water soluble coiled-coils (7). Leucine zipper proteins
have a characteristic seven amino acid repeat, (a b c d e/g)n, where the a and d
positions are occupied by hydrophobic amino acids and the e and g positions are
populated by polar acidic or basic amino acids. A hydrophobic interface is formed from
the side-to-side packing of the a and d residues that are aligned on the complementary
faces of two helices (8). The a and d positions of the helices in this work were modeled
after those amino acids found in the Jun oncogene product, with leucines at every
seventh position. Two different helices were designed such that the charge patterns at
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the e and g positions are largely acidic (A) or largely basic (B). Both of these peptide
domains have the propensity to form stable interchain homodimers in solution, and when
mixed in equimolar amounts, stable heterodimers (9). The three types of triblock
copolymers that were successfully prepared by biosynthetic methods are given below.
A-C-A
B-C-B
A-C-B
0 PKn^r^y>svn = a-Helical, Acidic
Leucine Zipper, A
= a-Heiical, Basic
Leucine Zipper, B
= [(AG)3PEG]l0or28.C
2.2 Experimental Section
2.2.1 Materials and Methods
Synthesis and Purification ofSingle Stranded DNA.
Oligonucleotides were synthesized on a Biosearch Model 8700 DNA synthesizer
by phosphoramidite chemistry developed by McBride and Caruthers (10) and cleaved
from polymer supports with 30% NH4OH at 65 °C. The glass beads were removed by
centrifugation and the decanted supernatant was dried in a speed vacuum. The
remaining pellets were then resuspended in 1 mL of deionized distilled water (ddHaO)
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and centrifliged at 1 5,800g (25 X) for 1 0 min to remove any insoluble materials. The
remaining aqueous solution ofDNA was adjusted to a final concentration of 10 mM
MgCb. Ethanol (100% equilibrated at 25 X) was added to the DNA solution in the
ratio of 3 : 1
.
The mixtures were then cooled at -70 X for 1 0 min and pelleted at 4 X
(15,800g) for 10 min. The supernatant was decanted and the pellet dried in the speed
vacuum. The resulting pellets were resuspended in 1 mL of ddH20 and single stranded
DNA was quantitated based on optical absorbance measurements at 260 nm.
Polyacrylamide gel electrophoresis (10%, 8 M urea) was used to purify the single
stranded DNA. Coding and noncoding strands (100 ^g) of Linkers 1 (1) and 2 (2)
shown in Figure 2. 1 were mixed with 2x formamide loading buffer and heated to 95 X
for 5 min before loading onto the preheated gel. These samples were electrophoresed at
constant voltage (350 V) for approximately 2 hrs. Purified bands of the DNA strands
were visualized by ethidium bromide and excised from the gel. Gel slices were crushed
in 1 mL of elution buffer (500 mM NH4OAC, 0. 1% sodium dodecyl sulfate (SDS), 10
mM MgOAc2, and 1 mM ethylenediaminetetraacetic acid (EDTA), dipotassium salt
dihydrate (pH 8.0)) and incubated overnight at 37 "C on a spin wheel. Gel residue was
removed by centrifijgation at 4 "C in filter vials and the supernatants were first extracted
with 1 -butanol to remove ethidium bromide and then treated with 1 0 [iL of Type II
oyster glycogen (10 }ig/mL), NaCl (250 mM), and 0.9 mL 100% EtOH. Mixtures were
precipitated at -20"C overnight and centrifuged at 4''C for 30 min. DNA pellets were
washed once with 500 |liL of cold EtOH (70%) and redissolved in 50 \iL of ddHaO.
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Phosphorylalion and Annealing ofSingle Stranded DMA.
Purified oligonucleotides (1; coding = 5 ng, noncoding = 5 ng and 2; coding = 5
jxg, noncoding = 5 ^ig) were suspended in 20-30 of ddHzO, 5 ^iL of lOx T4
polynucleotide kinase buffer (80 mM Tris-HCl pH 7.5, 20 mM dithiothreitol (DTT), 10
mM MgCb, and 1 mM ATP), 2 nL ofATP (100 mM), and 1 nL of T4 polynucleotide
kinase ( 1 0 Richardson units (11)), to make a final volume of 50 i^L. These tubes were
then incubated at 1,TC for 45 min and 1 of NaCl (5 M) was added to each vial to
make a final concentration of 100 mM. The mixtures were then placed in a 95 "C water
bath and allowed to equilibrate to room temperature over a 10 hr period. The annealed
duplexes were then extracted with 50:50 phenol: chloroform and washed once with 100%
chloroform. Isopropanol (100 \iL) and NaOAc (20 |iL, 3 M) were added to each vial
and these were placed in the -70 T freezer for 30 min. DNA duplexes were pelleted at
4T (1 5,800g) for 25 min and dried in the speed vacuum. Pellets were resuspended in
100 i^L ofddHaO.
Ligation of 1 and 2 Duplexes into pUC-18.
Pharmacia'^^ pUC-18 cloning vector (2.5 (12) was digested with EcoRI (2
units; 1 unit of restriction endonuclease activity is the amount of enzyme required to
completely digest 1 |ig of substrate DNA in a total reaction volume of 50 |iL) and
Hindlll (2 units) restriction enzymes. DNA was visualized on a 1% agarose gel with
ethidium bromide and the linearized pUC-18 band was cut and purified by Bio-Rad^^ gel
extraction kit. A 33 molar excess of linker to vector (equal volumes) was combined with
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2 ^lL of lOx ligase buffer (50 mM Tris-HCl (pH 7.8), 10 mM MgCb, 10 niM DTT, 1
mM ATP, 25 ng/mL bovine serum albumin (BSA)), 0.5 |.iL T4 ligase (15 Weiss units
(13), and 7 6 nL of water to make a total volume of 20 |aL. The mixtures were placed in
a 12-15 "C refrigerator for 21 hrs.
Transformation ofpUC-IH Conlainin^ 1 and 2 into I)H5al'" Compclcnl Cells.
DH5aF' cells were grown to an optical density (ODjso) of 0.573, placed on ice
for 10 min, and collected by centrifugation at 2000^' for 15 min at 4 "C. The cells were
then resuspended in 2 mL of TFBl Buffer (10 mM morpholino ethanesulfonic acid (pH
6.2) (MES), 100 mM RbCb, 10 mM CaCl2 2H20, and 50 mM MnCb^HzO) by gentle
tilting of the tube with the final volume being adjusted to 16 mL. This suspension was
left on ice for 1 5 min before the cells were pelleted at 2000^^'' for 1 5 min and resuspended
in TFB2 buffer (10 mM 3-(N-morpholino)propane sulfonic acid (MOPS), 75 mM
CaCl2 2H20, 10 mM RbCb, and 15% glycerol). The tube was left on ice for 15 min
before 200 |liL aliquots were dispensed into vials to be stored at -70 T. Competent cells
were then thawed on ice and 50 \iL of the cells were added to 10 |.iL of the ligation
mixtures. The vials were then placed on ice for 2 hrs and heat shocked at 42 "C for 3
min before placing them on ice for 5 min. 2xYT medium (500 \iL of 16 g Casein-
hydrolysate, 1 0 g yeast extract, 5 g NaCI per liter) was added to the mixtures and
incubated at 37 "C for 45 min. The cells were then spread onto agar plates containing
200 |ng/ml ampicillin and grown for 17 hrs.
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Mini-preps ofplJC-18 Comaining 1 and 2 Transformants.
pUC-18 cloning plasmids containing DNA 1 and 2 were designated as pWAP-Ll
and PWAP-L2 respectively (see Figure 2.2). Eight colonies ofpWAP-Ll and twelve
colonies ofpWAP-L2 were grown overnight in 2xYT medium containing ampicillin (200
^g/mL). The DNA from these cell cultures was purified by the following miniprep
protocol. A 1.5 mL saturated culture was spun at 1 3,600g for 2 min and the supernatant
poured off. The cells were resuspended in 200 ^iL ofGTE buffer (50 mM glucose, 25
mM Tris-HCl (pH 8), and 1 mM EDTA (pH 8.0)) by repeated pipetting. NaOAc (200
^L, 3 M, pH 4.8) was added to neutralize the solution and the mixture was incubated on
ice for 5 min. The white precipitate was collected by centriftigation at 13,600^ for 5
min. The clarified supernatant was transferred to a new 1.5 mL tube containing 2 i^L of
RNAse A (10 mg/mL) and incubated at 50 T for 30 min. Phenol: chloroform (50:50,
500 |iL) was added and the mixture was spun at 13,600g for 5 min. The aqueous layer
was decanted and washed once with chloroform. Isopropyl alcohol (500 i^L) was added.
DNA was precipitated at -20 "C for 30 min and pelleted at 4 °C, 13,600g for 30 min.
Supernatant was discarded and the DNA was resuspended into 100 |iL of ddH20 before
50 |iL of25% polyethylene glycol (PEG M.Wt. 8000)/2.5 M NaCl was added. This
mixture was incubated at -20°C for 30 min, centrifliged at 13,600^ for 30 min, and
resuspended in 50 |iL of ddHiO.
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Screening for Inserts 1 and 2 by Enzymatic Digestions.
To check for proper DNA insertion of 1 and 2 into pUC-18, restriction digests of
pWAP-Ll and pWAP-L2 were done by mixing 15 i^L of plasmid DNAs collected from
the miniprep above, 5 |^L ofNEB2 buffer (50 mM NaCl, 10 mM Tris-HCl, 10 mM
MgCb, 1 mM DTT, pH 7.9), 1 nL Hindlll (20 units), 1 Nhel (5 units), and 33 nL of
ddHzO to give a final volume of 50 ^L. These mixtures were then heated at 37 °C for 4
hrs. The digested DNA was visualized by ethidium bromide on a 1% agarose gel and
colonies with the proper inserts were saved for DNA sequencing. In addition to this
digestion, individual digestions for pWAP-Ll and pWAP-L2 were done as further
checks for insertion. pWAP-Ll (7 |^L) was digested with 0.5 |liL of Nrul (4 units), 2.5
NEBuffer Nrul (100 mM KCl, 50 mM Tris-HCl, 10 mM MgCb, pH 7.7), and 15 |iL
of ddHjO for a final volume of 25 |iL. pWAP-L2 was digested with 0. 5 |iL of Xhol ( 1
0
units), 2.5 \\L of NEB2 buffer, and 15 |^L of ddHzO. Again digested DNA was
visualized on a 1% agarose gel with ethidium bromide. pUC-18 was used as a positive
control since it contains neither Nrul nor Xhol restriction sites.
DNA Sequencing ofpWAP-Ll andpWAP-L2 Inserted into pUC-18 Cloning
Vector.
DNA sequences pWAP-Ll and pWAP-L2 were confirmed by the Sanger (14)
dideoxy method using USB Sequenase Version 2.0. 1™ sequencing protocol (15). Both
universal (M 1 3/pUC Sequencing Primer (-20) 1 7mer) and reverse (M 1 3/pUC Sequencing
Primer (-47)24mer) were used to read coding anticoding DNA strands respectively.
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Digestion and Removal ofPhospha/e Grovps ofpWAP-Ll andpWAP-L2.
pWAP-Ll (88 nL or approximately 220 ng) was first digested with 2.0 i^L of
Nrul (50.8 units) and 10 nL ofNrul buffer overnight at 37 T. DNA was precipitated
and isolated before being digested with 1.0 |aL of Sphl enzyme (5 units), 5 |iiL of NEB2
buffer, and 44 ^iL of ddH20 over 5 hrs at 37 X pWAP-L2 (88 i^L or approximately 1
^ig) was digested with 2.0 |iL BstEII (20 units) and 10 ^L NEB3 buffer (100 mM NaCl,
50 mM Tris-HCl, 10 mM MgCb, 1 mM DDT, pH 7.9) at 60 overnight. Both pWAP-
Ll and pWAP-L2 mixtures were heat inactivated for 20 min at 65 "C before 1 \iL of calf
intestinal alkaline phosphatase (CIP) (10 units) was added to the pWAP-Ll digestion
mixture and 8 \xh of CIP (80 units) was added to the pWAP-L2 digestion mixture.
EDTA was added to each solution to give a final concentration of 5 mM and the reaction
mixtures were heated to 65 "C for 1 hr. The DNA was extracted with phenol and
precipitated with 20 |aL ofNaOAc and 120 |^L of 100% EtOH. Dried DNA was then
resuspended in 40 |^L ofTE buffer (10 mM Tris-HCl, 1 mM EDTA, pH 8.0) before
being run on a 1% agarose gel. Gel slices were excised and purified by Bio-Rad DNA
purification method.
Insertion and Verification ofRandom Coil and Helical DNA Sequences into
LinearizedpWAP-Ll andpWAP-L2
.
DNA encoding [(AG)3PEG]io (3) (Figure 2.3) and [(AG)3PEG]28 (4) (Figure 2.4)
were ligated into linearized pWAP-Ll at Sphl/Nrul sites. In addition, DNA encoding a-
helical acidic leucine zipper (5) (Figure 2.5a) and basic leucine zipper (6) (Figure 2.5b)
were ligated into linearized pWAP-L2 at the BstEII site. Prior to ligation, DNA 3 and 4
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were obtained from pET3-5 and pET3-14 plasmids (16) respectively by cutting with
SphI and Nrul. Likewise, DNA 5 and 6 were digested from pUC-LINKAl (7) with
BstEII enzyme. Purified pieces were ligated into the linear pWAP-Ll or pWAP-L2 by
combining 10 of insert, 10 |aL of vector, 2.5 nL of ligase buffer, 0.5 nL of T4 DNA
ligase, and 2.0 nL of ddH20. The ligation mixtures were then used to transform
DH5aF' cells and the resultant transformants were screened for proper DNA insertion
by enzymatic digestions. Plasmids containing 3 or 4 were digested with Ndel and SphI
whereas plasmids containing 5 or 6 were digested with Ndel and Bglll. All of the
combined DNA were confirmed by the Sanger dideoxy sequencing method mentioned
previously. Plasmids were designated pWAP-LlCio, pWAP-LlCjs, pWAP-L2A, and
pWAP-L2B as shown in Figure 2.2.
Enzymatic Digestions ofDNA at Nhel and Spel Restriction Sites.
In order to recombine DNA described above to form DNA that encodes the
triblocks A-C-A, A-C-B, and B-C-B where A and B are acidic and basic leucine zipper
proteins and C is the random coil [(AG)3PEG]ioor28 repeat, a series of digestions and
ligations were done at the Nhel and Spel enzymatic restriction sites. Figures 2.6 and 2.7
represent two different routes to the coding sequences of the triblocks. The combination
ofDNA was achieved through Nhel and Spel sites located outside of the helix and coil
regions of the DNA. It is important to note that Nhe and Spel sites are compatible and
upon ligation of a Nhel to a Spel end or vice versa, the site is destroyed. Both
restriction sites have the same middle four nucleotide bases which allows them to
combine upon ligation (see below).
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Nhel 5' G C T A G C 3'
3' C G A T C G 5'
Spel 5' A C T A G T 3'
3' T G A T C A 5'
The frequency at which Nhel cut ends combine with Spel cut ends is approximately
50%. In all cases, Nhel and Spel digestions were done in a total volume of 25 |aL;
enzymatic buffer, enzyme, ddHsO, and DNA volumes were adjusted accordingly.
Miniprep, transformation, and phosphate removal procedures were described previously,
Agarose gels (2%) were used in verification, quantification, and isolation of the various
DNA.
DNA encoding twelve different proteins was made through the series of steps
outlined. These DNA are abbreviated as pWAP-L2A, pWAP-L2B, pWAP-LlC,o,
pWAP-Ll ACoA, pWAP-Ll AC,oB, pWAP-LlBC.oB, pWAP-L2AC,oA, pWAP-
L2AC,oB, pWAP-L2BC,oB, pWAP-L2ACu)A, pWAP-L2AC,oB, pWAP-L2BC,oB,
pWAP-L2AC28A, pWAP-L2AC2sB, and pWAP-L2BC28B. The difference between LI
and L2 designation is LI encodes for a single tryptophan at the C-terminus whereas L2
encodes for a single cysteine at this end.
BamHI Digestions ofpWAP-L2A, pWAP-L2B, pWAP-LlCw, pWAP-lJAC,(A,
pWAP-LIACoB, pWAP-LlBCS, pWAP-L2ACuA, pWAP-L2AC,oB,
pWAP-L2BC,oB, pWAP-L2AC2hA, pWAP-L2AC2hB, pWAP-I2BC2,B,
andpQK9.
pWAP-L2A, pWAP-L2B, pWAP-LlC,o, pWAP-Ll AC,oA, pWAP-Ll ACioB,
pWAP-LlBCoB, pWAP-L2AC,oA, pWAP-L2AC,oB, pWAP-L2BC,oB, pWAP-
L2AC2«A, pWAP-L2AC28B, and pWAP-L2BC28B DNA were grown in 100 mL 2xYT
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medium with ampicillin (200 ^g/mL) and isolated by 0,«^../,tm
^..jp^^p A columns.
Each plasmid (43 or approximately 300 ng) was combined with 5 nL of NEB
BamHI buffer (150 mM NaCl, 10 mM MgCl,, 1 mM DDT, pH 7.9) and 2 of BamHI
(40 units) and incubated overnight at 37 X (Figures 2.8 and 2.9). Qiagen^^ pQE9
expression vector (Chatsworth, CA) DNA was also cut with BamHI as above and
dephosphorylated by the CIP protocol as previously described (Figures 2.8 and 2.9).
The fragments were visualized on 2% agarose gels and excised for purification by Bio-
RacT^ DNA binding beads. Quantification of the recovered DNA was made on 2%
agarose gels.
Ligation ofpWAP-L2A, pWAP-L2B, pWAP-IJCi„, pWAP-LJAC,oA,
pWAP-LlACoB, pWAP-LlBCioB, pWAP-L2AC,oA, pWAP-L2AC,oB,
pWAP-L2BC,oB, pWAP-L2AC2sA, pWAP-L2AC2sB, andpWAP-L2BC28B
into pQE9.
A 5 molar excess of linker to vector was combined with 2.5 |^L ligation buffer,
0.5 [iL ligase, and ddH20 for a total volume of 25 ^iL. The ligated mixtures were
transformed into K-12 E. coli strain SGI 3009 {Qiagen'^^, Chatsworth, CA) containing
repressor plasmid, pREP4 {Qiagen™, Chatsworth, CA). Mixtures were spread onto
2xYT agar plates containing 200 \xg/mL ampicillin and 50 |ag/mL kanamycin and
incubated for 16 hrs at 37 "C. Single colonies were grown to saturation in 5 mL of
2xYT medium and the DNA isolated. Restriction digests were used to check
orientation, size, and digest sites of the transformed colonies. These were accomplished
with Nhel, EcoRI/Hindlll, and BamHI restriction enzymes respectively. Colonies
containing the correct inserts were then used for the following bacterial expression.
r
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Protein Expression iti pOE9-derived Expression Vectors.
Recombinant vectors (pQE9) containing the targeted sequences were used for
protein expression in host cells of strain SG13009 containing repressor plasmid (pREP4)
(Figures 2.8-2.9). New plasmid designations are pQE9-L2A, pQE9-L2B, pQE9-LlC,o,
pQE9-LlAC,oA, pQE9-LlACioB, pQE9-LlBCioB, pQE9-L2AC,oA, pQE9-L2AC,oB,
pQE9-L2BC,oB, pQE9-L2AC28A, pQE9-L2AC28B, and pQE9-L2BC28B with the
corresponding protein sequences designated 7-18 respectively. Saturated cultures
containing the targeted DNA sequences were grown in 25 mL of2xYT medium with
ampicillin (200 ^ig/mL) and kanamycin (50 |ig/mL) for 15 hrs at 37T. These cultures
were then transferred to 2 L flasks each containing 1 L sterilized 2xYT medium and
antibiotics. These were incubated for an additional 6 hrs at 37°C with vigorous aeration
until optical densities (600 nm, ODgoo) were in excess of 2. IPTG (1 mM) was added
and protein synthesis was induced for a period of 4 hours at 37T. The cells were then
centrifliged (22, 100 x g for 30 min), supernatant removed, and 50 mL of 6 M guanidine-
HCl buffer containing Na2HP04 (0. 1 M, pH 8) was added. The cells were lysed by
storing in a -80 °C freezer before the supernatant was collected for protein purification
by centrifiigation at 22,100g for 50 min. The clarified supernatant was loaded onto a
nickel-NTA affinity column at pH 8 and the bound target proteins were washed with 8
M urea buffers at pH 8, 7, and 6 before being eluted at pH 5. The appropriate fractions
were dialyzed against deionized water before being freeze-dried. The final weights of
the purified target proteins were in the range of 50-1 50 mg per 1 L of cell growth
medium (Table 2.1).
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mass
Matrix Assisted Laser Desorption Mass Spectrometry with Time-of-F/i^rht
Analyzer (TOF).
Matrix assisted laser desorption mass spectrometry was used to analyze the
of gas-phase protein ions. MALDI-TOF mass spectrometry was performed on a
Lasermat 2000™ {Finnigari Mat, San Jose,CA) by the Analytical Chemistry and
Peptide/DNA Synthesis Facility at Cornell University, Ithaca, NY. The protein samples
(1-10 \xM) were mixed with a molar excess of matrix solution ( 3,5-dimethoxy-4-
hydroxycinnamic acid (0.05 M) for masses greater than 20,000 and a-cyano-4-
hydroxycinnamic acid (0.05 M) for masses less than 20,000 in 30% acetonitrile/water,
0.1% trifluoroacetic acid) before approximately 0.5 |iL was dried onto the sample probe
The surface of the probe was irradiated with a nitrogen pulsed laser at 337 nm.
Detection of the protein ions was recorded in the positive ion mode with individual
spectra being obtained with single laser shots of about 10*^ W/cm^ irradiance. An
accelerating vohage of 20 keV was used.
Quantitative Amino Acid Compositional Analysis.
Amino acid analysis was performed by the Analytical Chemistry and
Peptide/DNA Synthesis Facility at Cornell University, Ithaca, NY. Amino acid analysis
was carried out on a Pico-Tag Amino Acid Analysis System (17). Duplicate samples
were hydrolyzed in constant boiling HCl at 150 "C for 110 min.. Appropriate blanks,
controls and standards were hydrolyzed in the same vessel as the batch hydrolysis. The
amino acids were derivatized with phenyl isothiocyanate (PITC) and analyzed by
reversed phase HPLC (18, 19). The resulting phenylthiocarbamoyl amino acid
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derivatives were separated on a 4.6 x 300 mm Nova Pack^M C18 column employing a
modified Pico-Tag buffer system and detected at 254 nm.
Polyacrylamide Gel Electrophoresis.
Purified proteins were resolved on a polyacrylamide minigel by the method of
Laemmli (20) and visualized by staining with Coomassie Brilliant Blue R-250.
2.3 Results and Discussion
2.3.1 Synthesis and Characterization
The cloning and expression strategies used to assemble DNA encoding the helix,
coil, or helix-coil-helix motifs are shown in Figures 2.2 and 2.6-2.9. Two separate DNA,
1 and 2 (Figure 2. 1), were designed and synthesized in order to manipulate DNA (3, 4,
5, and 6) that encodes the helical or random coil domains (Figures 2.3-2.5). DNAs 1
and 2 were chemically synthesized and verified by sequencing of both coding and
noncoding strands in pUC 1 8 cloning plasmid. DNAs 3-6 were previously designed by
McGrath et al. (7, 20) and verification of these DNA after insertion into the appropriate
restriction sites was made by DNA sequencing. The combination ofDNA encoding for
helix and random coil was accomplished with Nhel and Spel restriction sites. By cutting
with both restriction sites, ligating the appropriate DNA fragments, and verifying the
orientation of the DNA, helix-coil-helix DNA were isolated by two pathways (Figures
2.6 and 2.7). DNA designated pWAP-LI AC,„A, pWAP-Ll AC.oB, and pWAP-LlBCioB
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encodes for a single tryptophan at the C-terminus end (Figure 2.6). On the other hand,
DNA designated pWAP-L2ACh,A, pWAP-I,2AC,oB, pWAP-L2BC,oB, pWAI>-
L2AC,hA, pWAP-L2AC,sB, and pWAP-L2BC,hB encodes for a single cysteine at the
C-terminus end (Figure 2.7). Finally, all DNA were cut at Banil 11 restriction sites,
purified, and ligated into the single Banilll restriction site in the pQHQ
expression vector (figures 2.8 and 2.9). In the pQE9 plasmid, a sequence of six
histidines are placed at the N-terminus of the protein. This sequence can be used for
rapid purification of the targeted proteins with Ni" metal affinity chromatography.
The molar masses of the recombinant proteins were verified by matrix-assisted
laser desorption mass spectrometry (MALDl) (21) and purity was assayed by amino acid
compositional analysis. The calculated and observed masses of the protonated polymers
are shown in I<'igures 2. 10-2.21 and summarized in Table 2.2. 1 he expected and
observed molecular masses vary for each protein. The precision of mass determination
using RNaseA as the calibration is 0. 1% (22). Counter ion association is believed to
account for the higher observed masses of Proteins 9-18 It should be mentioned that
previous MALDl experiments done by Beavis cl a/. (23) on [(AG)4PEG]i4 revealed two
alanine-to-valine substitutions in the expressed proteins. It is possible that this could
have occurred in the [(AG)^PEG]n containing proteins. However, amino acid analysis
does not support this statement and shows that all amino acid analyses were within 5%
of the theoretical values (Tables 2.3-2.8). In addition to the [Mill]' peak, a set of
periodic low molecular weight mass fragments is found for 9 (Figure 2. 12) in the 5- 1 OK
molecular weight range. The mass diflerences between these small peaks are in the
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range of 572 to 678 and they most likely correspond to the ionization of a single
alanylglycine repeat unit, [(AOsPEG], which has a molecular weight of 667.
Purified proteins were resolved on a polyacrylamide minigel by the method of
Laemmli and visuaHzed by staining with Coomassie Brilliant Blue R-250 (Figures 2.22
and 2.23). All of the proteins, with the exception of 7 and 8, migrate to molecular
weights higher than their calculated values. This is believed to result from the acidic
[(AG)3PEG]n protein for which an anomalously low rate of migration has been seen in
previous work (17, 24). One explanation for this is that the charge-to-mass ratios of the
SDS-polypeptide complexes are no longer uniform due to the acidic nature of the
polypeptides. Normally SDS-bound polypeptides are extended and rodlike in shape
whereas the proteins reported here may be more random coil in shape. The reduced
binding of SDS to the polypeptides is a result of the acidic groups remaining ionized or
negatively charged at pH 9 .5, which is the pH of the gel while an external electrical field
is applied. Electrophoretic mobility, |i, is defined as the steady-state velocity per unit
field and is given by,
[i-v/E, {1}
where v is the steady-state velocity of the molecule and E is the electric field, v is also
given as
v=qE/l {2}
where q is the charge of the molecule, and/is the frictioiial coefficient which reflects the
size and shape of the molecule (25). The results of having many charged acidic groups
on a chain may be to reduce SDS binding to the polypeptide chain, to lower the overall
charge density on the chain, and to decrease the steady-state velocity.
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In conclusion, twelve different macromolecules were synthesized by the cloning
strategy outlined. The design strategy is versatile in that it can be used to make a library
of proteins that can be easily modified at either the helical domain or the random coil
domain. It is our intention to investigate the gelation behavior of the triblock
copolymers when changing the charge pattern of the helical domain as well as the size
and the charge density of the random coil domain.
r
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(a)
licoRl BamHl
,Nhcl
5; AA IITC GGA TCC GAT GAC GAT GAC AAA GCT AGC
3 G CCT AGG CTA CTG CTA CTG TIT (GA TCG
^'''^ BstEII sphl SpelTAT CGC GAT GGT GAC CCG CGC ATG CCG ACT AGTATA GCG CTA CCA CTG GGC GCG TAC GGC TGA TCA
BamHI Ilindlll
TGG TAA GGA TCC A 3'
ACC ATT CCT AGG TTC GA 5'
(b)
EcoRI Bamill
5' AA TIC GGA TCC GAT
3' G CCT AGG CTA
BstEll
AGC GGT GAC CAT GTG
TCG CCA CTG GTA CAC
ATG GGT GGC TGC TAI
I
TAC CCA CCG ACG ATI 1
Nhel
GAC GAT GAC AAA TGG GCJ
CTG CTA CTG TTT ACC CGA
Xhol Spel
GCG CCT CGA GAC ACT AGT
CGC GGA GCT CTG TGA TCA
Bamlll Ilindlll
GGA TCC A 3'
CCT AGG TTC GA 5'
Figure 2. 1 Sequences of coding (5'-3') and noncoding (3'-5') DNA for (a) 1 and
(b) 2 incorporated into the Ilindlll and IxoRI restriction sites of cloning
vector pUC-18 Important restriction sites are underlined and I I indicates
a deletion of a nucleotide.
r
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\
EcoR I Hind III
EcoR I, Hind III
Figure 2.2 Strategy for cloning artificial genes encoding random coil and a-helix into
pUC18 plasmid DNA.
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Nrul BanI
C GAT CCG ATG GGT GCC
G CTA GGC TAC CCA CGG
CCG GAA GGT GCA GGC GCT
GGC CTT CCA CGT CCG CGA
BanI
GGT GCC GGC GCT GGT GCG
CCA CGG CCG CGA CCA CGC
GGC GCT GGT GCG GGC CCG
CCG CGA CCA CGC CCG GGC
GGT GCG GGC CCG GAA GGT
CCA CGC CCG GGC CTT CCA
BanI
GGC CCG GAA GGT GCC GGC
CCG GGC CTT CCA CGG CCG
GAA GGT GCA GGC GCT GGT
CTT CCA CGT CCG CGA CCA
GCC GGC GCT GGT GCG GGC
CGG CCG CGA CCA CGC CCG
GCT GGT GCG GGC CCG GAA
CGA CCA CGC CCG GGC CTT
GGC GCT GGT GCG GGC
CCG CGA CCA CGC CCG
GGT GCG GGC CCG GAA
CCA CGC CCG GGC CTT
GGC GGC GAA GGT GCA
CCG CCG CTT CCA CGT
BanI
GAA GGT GCC GGC GCT
CTT CCA CGG CCG CGA
GCA GGC GCT GGT GCG
CGT CCG CGA CCA CGC
GCT GGT GCG GGC CCG
CGA CCA CGC CCG GGC
BanI
GCG GGC CCG GAA GGJ
CGC CCG GGC CTT CCA
CCG GAA GGT GCA GGC
GGC CTT CCA CGT CCG
BanI SphI
GGT GCC CGC ATG 3'
CCA CGG GC 5'
Figure 2.3 Sequences of synthetic DNA 3 encoding for [(AG)?PEG]io inserted
into the Nrul and SphI restriction sites. Important restriction sites are
underlined.
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5'
3'
Nrul BanI
.^_^T CCG ATG GGLGCC GGC GCT GGT GCG GGCG CTA GGC TAG CCA CGG CCG CGA CCA CGC CCG
CCG GAA GGT GCA GGC GCT GGT GCG GGC CCG GAAGGC CTT CCA CGT CCG CGA CCA CGC CCG GGC CTT
BanI
QCC GGC GCT GGT GCG GGC GGC GAA GGT GCACCA CGG CCG CGA CCA CGC CCG CCG CTT CCA CGT
BanI
GGC GCT GGT GCG GGC CCG GAA GGT GCC GGC GCTCCG CGA CCA CGC CCG GGC CTT CCA CGG CCG CGA
GGT GCG GGC CCG GAA GGT GCA GGC GCT GGT GCG
CCA CGC CCG GGC CTT CCA CGT CCG CGA CCA CGC
BanI
GGC CCG GAA GGT GCC GGC GCT GGT GCG GGC CCG
CCG GGC CTT CCA CGG CCG CGA CCA CGC CCG GGC
BanI
GAA GGT GCA GGC GCT GGT GCG GGC CCG GAA GGJ
CTT CCA CGT CCG CGA CCA CGC CCG GGC CTT CCA
GCC GGC GCT GGT GCG GGC CCG GAA GGT GCA GGC
CGG CCG CGA CCA CGC CCG GGC CTT CCA CGT CCG
BanI
GCT GGT GCG GGC CCG GAA GGT GCC GGC GCT GGT
CGA CCA CGC CCG GGC CTT CCA CGG CCG CGA CCA
GCG GGC CCG GAA GGT GCA GGC GCT GGT GCG GGC
CGC CCG GGC CTT CCA CGT CCG CGA CCA CGC CCG
BanI
CCG GAA GGT GCC GGC GCT GGT GCG GGC CCG GAA
GGC CTT CCA CGG CCG CGA CCA CGC CCG GGC CTT
Continued
Figure 2.4 Sequence of synthetic DNA 4 encoding for [(AG)?PEG]28 inserted
into the Nrul and SphI restriction sites. Important restriction sites are
underlined.
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Contiiuicd
GGT GCA GGC GCT GGT CiCG GGC CCG GAA GGT (,( (CCA CGT CCG C(JA (CA CGC CCG GGC CTT CCA CGG
GGC GCT GGT GCG GGC CCG GAA GGT GCA (i(i(
CCG CCJA CCA CGC CCG G(iC CTT CCA CGT CCG CGA
BanI
GGT GCG GGC CCG GAA GGT GCC GG(^ GCV GG\ GCG
CCA CGC CCG GGC CTT CCA CGG CCG CGA CCA CGC
GGC CCG (iAA GGT GCA (JGC GCT G(JT GCG GGC CCG
CCG GGC CTT CCA CGT CCG CGA CCA CGC CCG GGC
BanI
GAA GQT OCC GGC GCT GGT GCG GGC CCG GAA GGT(IT CCA CGG CCG CGA CCA CGC CCG GGC CTT ((A
BanI
GCA GGC GCT GGT GCCJ GGC CCG GAA GGV GCC GGC
CGT CCG CGA CCA CGC CCG GGC C\\ CCA CGG CCG
GCT GGT GCG GGC CCG GAA GGT GCA GGC GCT GGT
CGA CCA CGC CCG GGC CTT CCA CGT CCG CGA CCA
BanI
GCG GGC CCG GAA GGT GCC GGC GCT GGT GCG GGC
CGC CCG GGC CTT CCA CGG CCG CGA CCA CGC CCG
CCG GAA GGT GCA GGC GCT GGT GCG GGC CCG GAA
GGC CIT (('A (GT CCG CGA CCA CGC CCG GGC CTT
BanI
GGT GCC GGC GCT GGT GCG GGC CCG GAA GGT GCA
CCA CGG CCG CGA CCA CGC CCG GGC CTT CCA CGT
BanI
GGC GCT G(iT GCG GGC CCG GAA GGI GCC GGC GCT
CCG CGA CCA CGC CCG GGC CTT CCA CGG CCG CGA
GGT GCG GGC CCG (iAA GGT GCA GGC GCT (iGT GCG
CCA ( (i(^ CCG GGC er r C( A CGT CCG CGA CCA CGC
BanI Sphl
GGC CCG GAA GGT GCC CGC ATG 3'
CCG GGC CTT CCA CGG GC 5'
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(a)
BstEII
5' GT_GAC_CTG GAA AAC
3' GAC CTT TTG
Bglll
AGG GAA GTT AGA TCT
TCC CTT CAA TCT AGA
GAA CTG GAA CAA AAA
CTT GAC CTT GTT TTT
GAA ATC GAA GAC CTG
CTT TAG CTT CTG GAC
GAA GTG GCC CAG CTG GGA
CTT CAC CGG GTC GAC CTT
CTG GAA GAT GAA GCG GCT
GAC CTT CTA CTT CGC CGA
Xhol
GTC TCG AGA CTG AAA AAT
CAG AGC TCT GAC TTT TTA
BstEII
AAA GCC GAA ATT G 5'
TTT CGG CTT TAA CCA CTG 3'
(b)
BstEII
5' GT GAC CTG AAA AAC
3' GAC TTT TTG
Bglll
AGG AAA GTT AGA TCT
TCC TTT CAA TCT AGA
GAA CTG AAA CAA GAA
CTT GAC TTT GTT CTT
GAA ATC GAA GAC CTG
CTT TAG CTT CTG GAC
AAA GTG GCC CAG CTG AAA
TTT CAC CGG GTC GAC TTT
CTG AAA GAT AAA GCG GCT
GAC TTT CTA TTT CGC CGA
Xhol
GTC TCG AGA CTG GAA AAT
CAG AGC TCT GAC CTT TTA
BstEII
AAA GCC AAA ATT G 5'
TTT CGG TTT TAA CCA CTG 3'
Figure 2.5 (a) Sequence of synthetic DNA 5 encoding for acidic leucine zipper and (b)
sequence of synthetic DNA 6 encoding for basic leucine zipper inserted into
BstEII restriction sites. Important sites are underlined
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Nhe I Spe I
EcoR I Hind HI
EcoRI
amp
Hind m
Figure 2.6 Strategy for cloning artificial genes encoding helix-coil-helix into
pWAP-LlCio.
$1
EcoR I Hind III
/ \
I
I I
INhcl Spel I
EcoR I Hind III
Nhcl
Nhc I. Spe I
Spe I
306 or 792 base pair fragment
T
Nhe I Spe!
EcoR I Hind HI
Spe! / X^Nhel.Spel
Nhc!
Spe I
156 base pair fragment
amp
lacZ'
EcoR I
/ ^
EcoR I
/
Hind III
\
Nhe I
1
Spel 1
Hind III
pWA P-L2AC
1oA>\ ^''i/'
pWAP-L2ACioB
pWAP-L2BCioB.
pWAP-L2AC28A.
I pWAP-L2AC28B.or
^ pWAP-L2BC28B
3310 or 3796 bi
EcoR I
r t
Spe I
T4 Ligasc
Figure 2.7 Alternate strategy for cloning artificial genes encoding helix-coil-helix
into pWAP-L2A and pWAP-L2B.
58
lad
I
EcoRI
/
lacZ'
\
Hind III
\
EcoRI Hind III EcoR
BamH I BamH I
BamHI
Hind III
BamHI
BamHI
BamHI
BamHI
T4 Ligase
BamH I EC9R I 88 Tl/rmB E.c. Hind III
: ii I
lambda to
BamHI
BamHI
1) Transform into
SG13009 with pREP4
repressor plasmid
2) IPTG
Target Proteins 7-9
EcoR I 88 BamHI
amp
Hind III
lambda to
Tl/rmB E.c.
Figure 2.8 Strategy for expressing artificial genes encoding helix or coil in
Oiageu^^ pQE9 plasmid DNA.
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EcoRI
BamHI BamHI
Hind HI EcoRl Hind III
BamHI
BamHI BamHI
I
BamHI
T4 Ligase
BamH I EcoR I 88 Tl/rmB E.c. Hind III
lambda to
BamHI
BamHI
^BamHI
1
r
BamHI
1) Transform into
SGI 3009 with pREP4
repressor plasmid
2) IPTG
Target Proteins 10-18
amp
EcoR I 88 BamHI
Hind III
lambda to
Tl/rmB E.c.
Figure 2.9 Strategy for expressing artificial genes encoding helix-coil-helix in
Qiagen™ pQE9 plasmid DNA.
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Table 2.
1
Protein yields per 1 L of cell growth medium after purification with Ni' '
metal affinity chromatography.
7 Acys 122.4
8 Beys 157.1
9 Ctrp 26.4
10 ACioAtrp 35.0
11 ACioBtrp 137.3
12 BCioBtrp 113.4
13 AC 10Acys 56.2
14 ACioBcys 104.2
15 BCioBcys 64.2
16 AC28Acys 22.3
17 ACzsBcys 52.4
18 BC28Bcys 26.7
*Yields are an average of 2 (IL) expressions.
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(a)
5'
MRGSHHHHHHGSDDDDKWASGDLENEVAQLEREVRSLEDEAAELEOKVSRL
KNEIEDLKAEIGDHVAPRDTSMGGC 3' v ^im.
Figure 2. 10 (a) Protein sequence 7 and (b) MALDI mass spectrum of 7 in a-cyano-4-
hydroxycinnamic acid with calculated molecular weight of 8549.
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(a)
5'
NmGSHHHHHHGSDDDDKWASGDLKNKVAQLKRKVRSLKDKAAELKQEVSR
LENEIEDLKAKIGDHVAPRDTSMGGC 3' V^-v^k
(b)
10.0-
9.5-
9.0-
8.5-
8.0-
7.5-
7.0-
8558.7
I
88 30.4
5.0-
13016
I 21524
25782 34
3d006
T r
2000 4000 6000 8000 10000 14000 18000 22000 26000 ' 30000 ' 34000 '
~^
—
> Mass (rn/z)
Figure 2.11 (a) Protein sequence 8 and (b) MALDI mass spectrum of 8 in a-cyano-4-
hydroxycinnamic acid with calculated molecular weight of 8544.
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(a)
5' MRGSHHHHHHGSDDDDKASYRDPMG[(AG)3PEG],oARMPTSW 3'
(b)
3000 4000 5000 6000 8000 ' 10000 ' 12000 * 14000 16000 19000 22000 25000 28000
Mass (m/z)
Figure 2. 1 2 (a) Protein sequence 9 and (b) MALDI mass spectrum of 9 in a-cyano-4-
hydroxycinnamic acid with calculated molecular weight of 10383.
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(a)
5'
MRGSHHHHHHGSDDDDKASGDLENEVAQLEREVRSLEDEAAELEQKVSRLK
NEIEDLKAEIGDHVAPRDTSYRDPMGl(AG)3PEG],oARMPTSGDLENEVAQLER
EVRSLEDEAAELEQKVSRLKNEIEDLKAEIGDHVAPRDTSW 3
'
(b)
Figure 2. 13 (a) Protein sequence 10 and (b) MALDI mass spectrum of 10 in 3,5-
dimethoxy-4-hydroxycinnamic acid with calculated molecular weight of
22091.
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(a)
5'
MRGSHHHHHHGSDDDDKASGDLENEVAQLEREVRSLEDEAAELEQKVSRLK
NEIEDLKAEIGDHVAPRDTSYRDPMG[(AG)3PEG],oARMPTSGDLKNKVAOLKR
KVRSLKDKAAELKQEVSRLENEIEDLKAKIGDHVAPRDTSW 3'
(b)
15.5
15.0
14.5
14.0
13.5-
13.0-
12.5-
12.0-
11.5
3<
11.04 7409.3
10.5
10.0
9.5
9.0
8.5
8.0
1^
11090
I
22133
44175
8000 10000 12000 1 6000 20000 24000 28000 32000 36000 40000 44000
\
Mass (m/z)
Figure 2. 14 (a) Protein sequence 11 and (b) MALDI mass spectrum of 11 in 3,5-
dimethoxy-4-hydroxycinnamic acid with calculated molecular weight of
22085.
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(a)
5'
MRGSHHHHHHGSDDDDKASGDLKNKVAQLKRKVRSLKDKAAELKQEVSRL
ENEIEDLKAKIGDHVAPRDTSYRDPMG[(AG)3PEGIioARMPTSGDLKNXVAQL
RKVRSLKDKAAELKQEVSRLENEIEDLKAKIGDHVAPRDTSW 3
'
(b)
22
21-
20-
19-
18-
17-
11106
I
22165
2081^
14812
13j*0i 17868
8000 10000 12000 16000 20000 24000 28000 32000 36000 40000 44000
Mass (m/z)
Figure 2. 1 5 (a) Protein sequence 12 and (b) MALDI mass spectrum of 12 in 3,5-
dimethoxy-4-hydroxycinnamic acid with calculated molecular weight of
22079.
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(a)
5' MRGSHHHHHHGSDDDDKWASGDLENEVAQLEREVRSLEDEAAELEQKVSR
LKNEIEDLKAEIGDHVAPRDTSYRDPMG[(AG)3PEGl,oARMPTSGDLENEVAQL
EREVRSLEDEAAELEQKVSRLKNEIEDLKAEIGDHVAPRDTSMGGC 3
'
(b)
Figure 2.16 (a) Protein sequence 13 and (b) MALDI mass spectrum of 13 in 3,5-
dimethoxy-4-hydroxycinnamic acid with calculated molecular weight of
22439.
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(a)
5' MRGSHHHHHHGSDDDDKWASGDLENEVAQLEREVRSLEDEAAELEQKVSR
LKNElEDLKAEIGDHVAPRDTSYRDPMG[(AG)3PEGl,oARMPTSGDLKNKVAQL
KRKVRSLKDKAAELKQEVSRLENEIEDLKAKIGDHVAPRDTSMGGC 3'
(b)
14.6
14.4'
11.8
6000 8000 10000 12000 14000 16000 ' 20000 ' 24000 ' 28000 32000
Mass (m/z)
Figure 2. 1 7 (a) Protein sequence 14 and (b) MALDl mass spectrum of 14 in 3,5-
dimethoxy-4-hydroxycinnamic acid with calculated molecular weight of
22433.
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(a)
MRGSHHHHHHGSDDDDKWASGDLKNKVAQLKRKVRSLKDKAAELKQEVSR
LENEIEDLKAK1GDHVAPRDTSYRDPMG|(AG)3PEG1,„ARMPTSGDLKNKVAQL
KRKVRSLKDKAAELKQEVSRLENEIEDLKAKIGDHVAPRDTSMGGC 3'
(b)
15.8
15.6
15.4
15.2
15.0-1
14.8
14.6
14.4
14.2
14.0
13.8
13.6
13.4
13.2-
13.0-
12.8-
12.6
12.4
12.2
12.0
7476.5
5606.0
^4
1937.6
634413
11.8
11208
16013
22402
I
6000 8000 10000 12000 14000 16000 18000 20000 24000 28000 32000
Mass (m/z)
Figure 2.18 (a) Protein sequence 15 and (b) MALDI mass spectrum of 15 in 3,5-
dimethoxy-4-hydroxycinnamic acid with calculated molecular weight of
22428.
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(a)
5'MRGSHHHHHHGSDDDDKWASGDLENEVAQLEREVRSLEDEAAELEQKVSR
LKNEIEDLKAEIGDHVAPRDTSYRDPMG1(AG).,PKG1:„ARMI>TSGDLENEVAQL
EREVRSLEDEAAELEQKVSRLKNEIEDLKAEIGDHVAPRDTSMGGC 3'
Figure 2. 19 (a) Protein sequence 16 and (b) MALDI mass spectrum of 16 in 3,5-
dimetlioxy-4-hydroxycinnamic acid witii calculated molecular weight of
34450.
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(a)
5'MRGSHHHHHHGSDDDDKWASGDLENEVAQLEREVRSLEDEAAFLEOKVSR
LKNEIEDLKAEIGDHVAPRDTSYRDPMG|(AG)3PEGhsARMPTSGDLKNKVA0L
KRKVRSLKDKAAELKQEVSRLENEIEDLKAKIGDHVAPRDTSMGGC 3'
(b)
Figure 2.20 (a) Protein sequence 17 and (b) MALDI mass spectrum of 17 in 3,5-
dimethoxy-4-hydroxycinnamic acid with calculated molecular weight of
34445.
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(a)
5'
MRGSHHHHHHGSDDDDKWASGDLKNKVAQLKRKVRSLKDK4.^ELKQEVSR
LENEIEDLKAKIGDHVAPRDTSYRDPMG((AG)3PEG],sARMPTSGDLKNKVA0L
KRKVRSLKDKAAELKQEVSRLENEIEDLKAKIGDHVAPRDTSMGGC 3'
(b)
15.6
15.5
15.4
15.3
15.2-i
15.1
15.0
14.9-
14.8-
14.7
14.6
14.5-{
14.4
14.3^
14.2
14.1
14.0
35712
I
17900
I
11953
I
8000 10000 12000 16000 20000 24000 28000 32000 36000 40000 -UCOO
Mass {m/z)
Figure 2.2 1 (a) Protein sequence 18 and (b) MALDI mass spectrum of 18 in 3,5-
dimethoxy-4-hydroxycinnamic acid with calculated molecular weight of
34439.
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Summary ofMALDI mass spectrometry data.
Protein
Domain
Structure
l^iVl 1 III
(calculated)*
[M+HJ
(observed)
relative error
(%)
7 Acys 8550 8548 0.02
8 Beys 8545 8559 0.16
9 Ctrp 10384 10433 0.47
10 ACioAtrp 22092 22317 1.02
11 ACioBtrp 22086 22133 0.21
12 BCioBtrp 22080 22165 0.38
13 AC 10Acys 22440 22478 0.17
14 ACioBcys 22434 22506 0.32
15 BCioBcys 22429 22402 0.12
16 AC28Acys 34451 33148 3.78
17 AC28Bcys 34446 34567 0.35
18 BCzgBcys 34440 35712 3.69
* Values are average molecular weights and refer lo the protonated form of the polypeptide.
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Table 2.3 Amino acid compositional analysis of proteins 7 and 8.
amino acid
mol %
(theor) 7
mol %
(obs) 7
mol %
(theor) 8
mol %
(obs) 8
aspartic acid +
asparagine 14.6 14.8 14 6 1 s s
glutamic acid +
glutamine 17.2 18.0 9.3 10 ^
serine 8.0 8.3 8.0
glycine 8.0 8.6 8.0 8 7
histidine 9.3 9.2 9.3 8.9
arginine 6.6 6.8 6.6 6 8
threonine 1.4 1.7 1.4 1.6
alanine 8.0 7.9 8.0 8.1
proline 1.4 1.6 1.4 1.4
tyrosine 0.0 0.2 0.0 0.1
valine 5.3 4.8 5.3 4.5
methionine 2.7 2.3 2.7 2.3
cysteine 1.4 1.2 1.4 0.8
isoleucine 2.7 2.4 2.7 2.5
leucine 8.0 6.9 8.0 7.6
phenylalanine 0.0 0.1 0.0 0.1
lysine 5.3 5.4 13.2 12.7
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Table 2.4 Amino acid compositional analysis of proteins 9 and 10.
amino acid
aspartic acid +
asparagine
glutamic acid +
glutamine
serine
glycine
histidine
arginine
threonine
alanine
proline
tyrosine
valine
methionine
cysteine
isoleucine
leucine
phenylalanine
lysine
mol %
(theor) 9
4.1
mol %
(obs)9
4.1
mol %
(theor) 10
8.5
mol
(obs) 10
8.4
8 9 o.U 16.0 14.7
3.3 3.3 4.4 4.8
35.3 36.5 20.8 18.6
5.0 5.0 3.6 3.6
2.5 2.9 4.9 5.1
0.9 0.8 1.4 2.4
26.3 25.8 18.6 16.8
9.9 10.1 6.2 6.0
0.9 0.9 0.5 1.1
0.0 0.1 3.6 4.3
2.5 1.4 1.3 0.9
0.0 0.1 0.0 0.1
0.0 0.0 1.8 2.5
0.0 0.1 5.3 6.2
0,0 0.1 0.0 0.9
0.9 0.8 3.1 3.5
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Table 2.5 Amino acid compositional analysis of proteins 11 and 12
ammo acid
mol %
(theor) 11
mol %
(obs) 11
mol %
(theor) 12
mol °/
(obs)
aspartic acid +
asparagine 8.5 8.3 8.5 7.9
glutamic acid +
glutamine 13.3 13.3 10.7 10.6
serine 4.4 4.4 4.4 4.6
glycine 20.8 21.0 20.8 21.4
histidine 3.6 3.5 3.6 3.8
arginine 4,9 5.0 4.9 5.0
threonine 1.4 1.3 1.4 1.4
alanine 18.6 18.5 18.6 18.6
proline 6.2 6.3 6.2 6.2
tyrosine 0.5 0.6 0.5 0.5
valine 3.6 3.5 3.6 3.4
methionine 1.3 1.3 1.3 0.8
cysteine 0.0 0.1 0.0 0.1
isoleucine 1.8 1.8 1.8 1.7
leucine 5.3 5.5 5.3 5.5
phenylalanine 0.0 0.1 0.0 0.1
lysine 5.8 5.6 8.4 8.4
77
Table 2.6 Amino acid compositional analysis of proteins 13 and 14.
amino acid
mol % mol % inoi /o mol %
(theor) 13 (obs) 13 l^ODS) 14
aspartic acid +
asparagine 8 3 7 S O.J 11
glutamic acid +
glutamine 15.7 15 6 11 1
serine 4.4 4 5 J. 1
glycine 21.3 22 6
histidine 3.5 3 3
arginine 4.8 4.9 4.8
threonine 1.3 1.2 1 3
alanine 18.3 18.4 18.3 17.6
proline 6.1 6.3 6.1 6.7
tyrosine 0.5 0.5 0.5 0.6
valine 3.5 3.2 3.5 3.3
methionine 1.8 1.7 1.8 1.8
cysteine 0.5 0.3 0.5 0.3
isoleucine 1.8 1.6 1.8 1.7
leucine 5.2 5.3 5.2 5.1
phenylalanine 0.0 0,2 0.0 0.3
lysine 3.1 3.0 5.7 5.1
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Table 2.7 Amino acid compositional analysis of proteins 15 and 16
amino acid
aspartic acid +
asparagine
glutamic acid
glutamine
serine
glycine
histidine
arginine
threonine
alanine
proline
tyrosine
valine
methionine
cysteine
isoleucine
leucine
phenylalanine
lysine
mol %
(theor) 15
mol %
(obs) 15
mol %
(theor) 16
mol %
(obs) 16
8.3 8.6 4 9 J.Z
10.5 10.5 1 ^
. o 1 1 1
4.4 5 8 z.o 2.9
21.3 19.7 30.9 30.3
3.5 3.9 2.1 2.5
4.8 4.9 2.8 3.3
1.3 1.4 0.8 0.9
18.3 16.5 24.5 23.7
6.1 5.8 8.2 8.1
0.5 0.6 0.3 0.5
3.5 3.7 2.1 2.2
1.8 1.4 1.0 0.8
0.5 0.1 0.3 0.1
1.8 1.9 1.0 1.0
5.2 6.7 3.1 3.2
0.0 0.1 0.0 0.1
8.3 8.4 1.8 1.9
9
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Table 2.8 Amino acid compositional analysis of proteins 17 and 18.
amino acid
mol % 111^1 /O moi To in/mol %
(theor) 17 Vineorj lo (obs) 18
aspartic acid +
asparagine 4.9 A n 5.0
glutamic acid +
glutamine 12.3 1 9 n lU. / 1 A *>10.3
serine 2.6 2 6 9 ^z.o 1 1
glycine 30.9 31 5 '^n 7ju. /
histidine 2.1 2 2 7 1
arginine 2.8 2 9 z. o 9 O
threonine 0.8 0.7 0 8
alanine 24.5 24 7 94 S 1\ 7
proline 8.2 8.3 8.2 8.3
tyrosine 0.3 0.4 0.3 0.4
valine 2.1 1.9 2.1 2.1
methionine 1,0 0.7 1.0 0.6
cysteine 0.3 0.2 0.3 0.1
isoleucine 1.0 0.9 1.0 1.1
leucine 3.1 3.1 3.1 3.8
phenylalanine 0.0 0.0 0.0 0.1
lysine 3.3 3.0 4.9 4.5
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M 8 M
43 kD
29 IcD
18 4kD
14.3 kD
6.2 kD
43 kD *
1 00 Vr\
1 KJJ —
18.4 kD ^
14.3 kD
^
1
^
M - Std. molecular
weight markers
7 =8549
8 =8544
9 = 10383
M 10 11 12
68 kD
43 kD *^
18.4 kD
14.3 kD
M - Std. molecular
weight markers
10 =22091
11 =22085
12 =22079
Figure 2.22 Purified protems 7-12 visualized on a 14% sodium dodecyl
sulfate (SDS)-polyacrylamide gel with Coomassie Brilliant
Blue R-250. Calculated molecular weights are shown.
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M 13 14 15
43 kD
29 kD
18.4 kD
14.3 kD
6.2 kD
M = Std. molecular
weight markers
13 =22439
14 =22433
15 =22428
M 16 17 18
68 kD ""^ IiAI^JMH " St4. molecular
43 kD •^ weight markers
16 =34450
17 =34445
18 =34439
Figure 2.23 Purified proteins 13-18 visualized on a 14% sodium dodecyl
sulfate (SDS)-polyacrylamide gel with Coomassie Brilliant
Blue R-250. Calculated molecular weights are shown.
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CHAPTER 3
REVERSIBLE HYDROGELS FROM SELF-ASSEMBLING ARTIFICIAL
PROTEINS
3.1 Objectives
Recombinant DNA technology was used to create a new class of protein-based
materials that contain naturally occurring a-helical coiled coil protein ends, that act as
physical crosslinks, separated by an artificial random coil poly(alanylglycine) protein,
[(AG)3PEG]io, that acts as a flexible spacer. The physical aggregation of the terminal
helices produces a three-dimensional network, with the flexible random coil retaining
solvent and preventing precipitation of the chain. The result is physical gelation that is
responsive to both pH and temperature changes. The reversibility of gelation results
from the destabilizing effects ofpH and temperature on the electrostatic and
hydrophobic interactions of the helical ends. An investigation of the acidic helical
protein (7), random coil poly(alanylglycine) protein (9), and acidic triblock copolymer
protein (13) shown in Figure 3.1 will be presented. Both pH and temperature
dependence of the three proteins in solution will be discussed in addition to the pH,
temperature, and concentration dependence of gelation of protein 13.
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3.2 Introduction
Protein engineering of new functional macromolecular materials promises to be a
valuable tool in creating novel polymers for biomedical applications. For instance, the
combination of natural protein domains with artificial domains provides a pathway for
making materials that have both functional and structural properties. These properties
determine how a material responds to a combination of environmental stimuli such as
pH, ionic strength, temperature, pressure, and various constituent molecules, Hydrogels
are a special class of functional materials that respond to difiFerent kinds of stimuli in
aqueous environments. They can be designed to swell or shrink under certain
physiological conditions (1) and they can be used to encapsulated cells, drugs, and other
molecules for site specific use (2-6).
The combination of both ionic and hydrophobic blocks within a synthetic
polymeric chain has been shown to yield pH and temperature sensitive gelled networks.
Chen et al. (7) have designed graft copolymers of poly(N-isopropyl acrylamide)
(PNIPAAm) and poly(acrylic acid) (PAAc) to investigate the response of the chain to
changes in temperature and pH with changes in copolymer composition. The results
show that graft copolymers having between 50 and 80 wt% AAc have lower critical
solution temperatures (LCST) that are pH dependent. The ionization of the -COOH
affects the hydrogen bonding interactions between the grafted NIPAAm and the
backbone AAc groups. The authors suggest that the temperature-induced pH-dependent
behavior of these graft copolymers may be fabricated into hydrogels. A similar study
involved preparing hydrogels of graft copolymers of polyethyleneglycol (PEG) on a
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polyCmethacrylic acid) (PMMAc) backbone (8). Hydrogen bonded complexes were
obtained between the -O- and
-COOH groups at low pH. Temperature sensitivity was
achieved at pH 4 but not at pH 7.4 where the gels were highly swollen.
In addition to the gels described above, chemically cross-linked gels can also
exhibit pH and temperature dependent behavior. Annaka et al. (9) have prepared
copolymer gels of acrylic acid and methacryl-amido-propyl-trimethyl ammonium chloride
by free radical polymerization. Both electrostatic (attractive or repulsive) and hydrogen
bonding interactions result in the existence of several phases with both pH and
temperature changes. These phases were determined by measuring the equilibrium
swelling degree of a cylindrically shaped gel sample. Reversible swelling with pH and
denaturant was found to exist in chemically cross-linked protein gels by the same group
(10).
Our interests are to synthesize protein-based materials that behave as pH and
thermally reversible hydrogels. By using genetic engineering principles, variables such as
sequence, stereochemistry, and length are precisely controlled. In turn, it is possible to
create non-covalent protein networks where the strength of the physical crosslinks, the
pH and temperature at which the materials gel, and the pore size are also controlled.
Reported herein is one of the block copolymers synthesized through genetic engineering
techniques that has both pH and temperature sensitive domains within the polymer
backbone.
Natural protein domains that are being used to control the gelation process are of
a well-known class of a-helical proteins, coiled-coils. Transcriptional regulatory
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proteins of this class include yeast GNC4 (1 1, 12) and mammalian C/EBP (13) and
nuclear transforming proteins of this class include Jun, Fos, and Myc (1 1-17). The
essential features of coiled-coil proteins are found in the sequence of seven amino acids
that repeat a minimum of four times (18) to form a 7^ a-helical structure (1 1) , In the
general heptad repeat denoted {abed efgX^ a and d positions are hydrophobic residues
that facilitate and stabilize interchain association of a-helices by forming complementary
hydrophobic helical faces that interact through hydrophobic and van der Waals
interactions ( 1 9-22). In addition to the hydrophobic core, which is formed by the side-
to-side packing of the a and residues, the formation of coiled-coils is further modulated
by interactions between regularly spaced charged groups at the e and g positions. The
stabilization of the super coiled helices is enhanced or diminished by positioning
attractive or repulsive charged groups at these positions (22, 23) and the propensity to
form parallel or antiparallel coiled-coils is dependent on the charge-charge interactions
between helices (24, 25).
The properties of both coiled-coils and a disordered water soluble protein,
[(AG)3PEG]
10' being combined to form a triblock protein that self-assembles into a
three dimensional network where the a-helical regions are designed to be the physical
crosslinks and the alanylglycine portion as the solvent-swollen domain. The amino acid
sequences of the proteins being investigated are shown in Figure 3.1. The Helix, which
contains a 42 amino acid sequence (six internal heptad repeats, ahcdefg), constitutes the
coiled-coil region. The choice of residues at positions a and d was based on the a / J
residue patterns see in the Jun oncogene product (26), which forms a weakly stabilized
homodimer. An algorithm developed by Lupas et al. (27), which identifies the most
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probable amino acids at positions a-g, was used to select residues occupying b, c, and/
positions in coiled-coils. Residues that would increase the solubility of the coiled-coil
complex in water were chosen first for these positions. Acidic or basic groups, glutamic
acid and lysine, respectively, were placed at the e and g positions to provide
intermolecular attraction or repulsion between chains. The coil domain used in the
design is the polyelectrolyte, [(AG)3PEG],o, which was previously shown (28) to adopt
disordered coil structures in solution and in the solid state.
3.3 Experimental
3.3.1 Biosynthesis of Macromolecules
Oligonucleotides were synthesized on a BiosearcH^^ Model 8700 DNA
synthesizer by phosphoramidite chemistry (29) and ligated into the polylinker region of
the pUC18 cloning vector (30), A 213 bp fragment encoding a-helical protein 7 was
ligated into the EcoRI and Hindlll restriction sites of pUC18 to yield pWAP-L2A.
Likewise, a 35 1 bp fragment encoding random coil protein 9 was ligated into the EcoRI
and Hindlll restriction sites of pUC18 to yield pWAP-LlC. Recombinant DNA was
cloned in E.coli strain DHSaF' before coding and non-coding sequences were verified by
DNA sequence analysis. DNA fragments that encode 7 and 9 independently were used to
form recombinant DNA that encodes for 13. This combination ofDNA was achieved
through Nhe 1 and Spe I sites. All DNA fragments were isolated by BamHI digestion,
and directionally ligated into the E. coli expression vector pQE9 (Qiagen, Chatsworth,
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CA) to form a NH.-terminal His ft^sion product The pQFO plasmid contains an coli
phage T5 promoter and two lac operator sequences Recombina.it I3NA plasmids
encoding 7, 9, and 13 were designated pQR9-L2A, pQE9-LlC,o, and pQE9-L2AC,oA
respectively. Each of these DNA sequences contain a e.Ucrokinase cleavage site directly
after the His tag. The host used for protein expression was col, strain SGI 3009
containing pREP4 repressor plasmid (Qiagen, Chatsworth, CA). Cultures containing
these DNA sequences were grown at 37 X in 2 L ofTB medium (16 g Bacto-Tryptone,
10 g Yeast Extract, 5 g NaCl per liter) with ampicillin (100 ^ig/ml) and kanamycin (50
^g/ml) until the optical densities (600 nm, ODooo) were in excess of 2. Isopropyl-P-
thiogalactoside (IPTG) (1 mM) was added and protein synthesis was induced for a
period of 4 hours at 37"C. The cells were then centrifuged (22100^^ for 30 minutes) and
50 ml 6 M guanidine-HCI bulTer containing Na2liP04 (0. 1 M, pH 8) was added The
cells were lysed by storing in a -80 "C freezer and the supernatant was collected for
protein purification Purification of the target proteins was achieved by metal alTinity
chromatography using a nickelnitrilotriacclic acid (Ni^'-NTA) resin supplied by
Qiaireti^^. Purified protein yields of 7, 9, and 13 are 122 mg, 26 mg, and 56 mg per liter
of growth medium respectively.
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3-3.2 Characterization of Artificial ProtpinQ
^•^•^^ Additional Purification andVenficatjon of Protein Svnthesis
Reversed phase high performance liquid chromatograms were acquired on
a WatersTM yiTplus Autosampler, 486 Tunable Absorbance Detector, and 600
Controller that was equipped with a Vydac™ C18 column (Supelco, Bellefonte, PA).
Proteins were dissolved in distilled, deionized water and filtered (0.22 ^m) prior to
injection, Elution profiles were monitored at 215 nm with a linear 2% gradient of water
(0. 1% trifluoroacetic acid) to acetonitrile that was run over a period of 60 minutes at a
flow rate of 1 mL/min (Figure 3.2). Solvents were purged with helium. Amino acid
compositional analysis as well as matrix assisted laser desorption mass spectrometry
(MALDI-MS) were performed in the Analytical Chemistry and Peptide/DNA Synthesis
Facility at Cornell University. Amino acid compositional analysis was made on a Pico-
Tag Amino Acid Analysis System {Millipore Corp., Bedford, MA), Amino acids were
derivatized with phenyl isothiocyanate (PITC) and analyzed by reversed phase-HPLC
with a 4.6 x 300 mm Nova Pack CIS column {Waters Corp., Bedford, MA). All amino
acid analyses were within 5% of the theoretical values. For MALDI experiments,
protein samples (1-10 |liM) were mixed with a molar excess of matrix solufion (3,5-
dimethoxy-4-hydroxycinnamic acid (0.05 M) for masses greater than 20,000 and a-
cyano-4-hydroxycinnamic acid (0.05 M) for masses less than 20,000 in 30%
acetonitrile/water, 0. 1% trifluoroacetic acid). The probe surface was irradiated with
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nitrogen pulsed laser at 337 nm. Detection of the protein ions was recorded in the
positive ion mode with individual spectra being obtained with single laser shots of about
10^ W/cm^ irradiance. An accelerating voltage of 20 keV was used. The calculated
mass of the 7 is 8549 and a peak at 8548 was found. Likew.se, the calculated mass of 9
is 10383 and the peak at 10433 was reported and the calculated mass of 13 is 22439
whereas the mass analysis gave a peak at 22478.
3-3.2.2 Circular Dichroism (CD) Measurements
CD spectra were recorded on an Aviv 62DS spectropolarimeter
(Lakewood, NJ) in 10 mM NaH2P04, 150 mM NaCl, pH 7.4 (adjusted with 1 N NaOH).
Final protein solution concentrations (after preparing 1 mg/ml filtered with 0.22 |im
cellulose acetate membranes) were determined by amino acid analysis. Wavelengths
from 250 nm to 195 nm were scanned at 1.0 nm bandwidth with points taken every 0.5
nm. Experiments were performed in a 1 mm path length rectangular cell (Helma) at 25
°C. The instrument was calibrated with an aqueous solution of (lS)-(+)-(10)-
camphorsulfonic acid; constant N2 flushing was employed. Mean residue molar
ellipticity is reported at wavelengths 195-250 nm ([9], deg cm^ dmol"') and is calculated
from the following equation: [6] = [GJobs x MRW/(c x 1), where [0]obs is ellipticity
measured in millidegrees, MRW is the mean residue molecular weight or the molecular
weight of the peptide divided by the number of amino acid residues, c is the peptide
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concentration in g/L determined by quantitative amino acid analysis, and I is the optical
path length in mm.
The calculation of protein secondary structure in solution was performed by three
different selection procedures: ridge regression, variable selection, and neural networks.
AVIVCD data files were converted to the proper format prior to running each program.
The three different selection methods are described below. All programs were obtained
from Dr. N. J. Greenfield (31).
Ridge Regression Analysis (CONTIN). The version of the CONTIN program, by
Provenchur and Glockner (32), was provided by Dr. S.Y. Venyaminov (Dept.
Biochemistry and Molecular Biology, Mayo Foundation, Rochester, MN) and uses a
variation of the method of least squares (33). The CD spectrum of an unknown protein
can be fit by a linear combination of spectra of known conformation. The basis set used
in this analysis has 16 original reference proteins plus poly-L-glutamate. Four basis
structures were evaluated: a-helix, p-sheet, P-turn, and remainder. The errors
associated with each calculation are reported as the variance.
Self-Consistent Method (SELCON). The SELCON program was provided by
R.W. Woody with the original FORTRAN source code from Sreerama and Woody (34,
35) modified to run on a personal computer. Four basis structures were evaluated: a-
helix, beta, turn, and other. Thirty-three protein reference spectra (36) were used. Basis
set proteins are arranged in order of increasing root-mean-square (RMS) differences
from the CD spectra of the protein to be analyzed. Spectra which are least like the
spectrum of interest are systematically deleted. A series of iterations are made before
self-consistency is obtained. Errors are reported in standard deviation.
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Neural Networks (K2D). The K2D neural net analysis program was provided by
Dr. M. Andrade. This algorithm (37) evaluates data between 200-240 nm to form 40
input neurons which are designated as the real neuron CD spectrum. In the "training-
phase, connections are made between input of the real CD spectrum with those of
protein standards. The weights of the connections are adjusted until the error between
the calculated and the actual secondary structure is minimized. This is reported as the
square of the euclidean distance between the real and the winning neuron CD spectra.
This distance gives an estimation of the mean error in the prediction of values for a-
helix, beta, and random secondary structures. If the distance larger than 0.08, the
prediction will not be reliable.
Thermal melting curves were determined by monitoring the CD signal at 222 nm
as a function of temperature, The signal was collected every 1 T with an equilibration
time of 1 minute. Spectra were collected in 10 mM NaH2P04, 150 mM NaCl (pH
adjusted with 1 N HCl or 1 N NaOH; equilibrated overnight). A thermostatically
controlled cuvette holder (HP Model 89101 A) was used to regulate the temperature to
within ±0.2 °C. A two state mechanism was used to describe the equilibrium between
folded and unfolded protein states. From this two state model, the thermal unfolding
temperature or the temperature where the fraction unfolded is equal to fraction folded
(AG =0) was determined by taking the first derivative of the CD signal, [0]222 nn„ with
respect to temperature'' (K) and finding the minimum of this function (38, 26). All
thermal melts were repeated in order to check reversibility; T^ values were within ±2 °C
of each other.
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^•3-2.3 Diffusing Wave Spectrnsrnpy
The dynamic intensity auto correlation function of multiply-scattered light from a
dilute suspension (0.5% solids diluted from stock) of tracer particles was measured with
a Coherenf^^ Laser source (512 nm, 100 mW) in a transmission geometry. A single
photon correlator with correlation software {ALV, Germany) was used. The tracer
particles, 0.3 ^m sulfonated polystyrene beads (SPS) (obtained stock as 8.8% solids,
surface charge density of 1
.5 |iC/cm^ area per charge group of 1060 A'/group) were
obtained from Interfacial Dynamics Corporation. Samples were placed into a 10mm x
5mm X 45mm optical glass cuvette {NSG Precision Cell) and data was collected for a
duration of six hours. Preparation of the latex suspensions was accomplished as follows.
Purified protein (50 mg) was placed into the glass cuvette where 943 ^L of
tris(hydroxymethyl)aminomethane (Tris) (buffering range of 6.9-7. 1) was added. The
sample was mixed thoroughly before 1 fiL volumes ofKOH (8M) were added
incrementally to change the pH. The gel containing the SPS beads was left for
approximately three days to equilibrate at which time additional KOH was added if the
desired pH was not found. The final volume of the gel containing SPS beads was
adjusted to 1 mL once the pH of the gel stabilized. The final concentration of the gel
was 5% (w/v). Concentration studies were made with samples prepared by diluting this
volume.
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3 3.2.4 UV-Vis Measurements
The reaction of 5,5'-dithiobis(2-nitrobenzoic acid) (Oilman's reagent) with
protein 13 in buffered solutions (10 mM Na.HPOa, 150 niM NaCl, pH 7.9 or 10 mM
Tris, pH 7.
1 ) was monitored at 4 1 2 nm with a Hitachi Model U-2000 Double-Beam
UV/Vis spectrophotometer. The amount of free thiol in solution was calculated by
measuring the amount of colored anion produced over time with the following equation,
Co = A/e X 1
1 1
1
where C„ is the molar concentration of free thiol in solution, A is the absorbance at 412
nm, 8 is the extinction coefficient of the colored anion (13,600 M/cm), and 1 is path
length (1 cm). The reaction of P-mercaptoethanol with F.liman's reagent was used as a
control. To a I mL sample (300 \xL of protein solution, 500 water, 200 of
buffer) 7.6 |.iL of Ellman's reagent (0.01 M) was added. Absorbance was monitored up
to 600 seconds following addition of the reagent.
3.4 Results and Discussion
The leucine zipper helix in the recombinant proteins contains six heptad repeats,
and so is 42 amino acids in length. The charge pattern at the e and positions in the
heptad repeat, shown as underlined amino acids in Figure 3. 1, is largely derived from
glutamic acid. In addition to the enrichment of acid functionality in the helical portion,
the disordered coil domain contains a glutamic acid in one out of every nine amino acids.
The triblock design is a combination of both helix and coil such that each chain will have
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regions of high charge density (the helical domains) separated by regions of low charge
density (the coil domain). More specifically, the high charge density region results from
the localization of charges on the 7. helix where the a and J positions align on one face
of the helix and the
.
and ^ positions are on either side of them. Adjacent helices will
form favorable hydrophobic interactions but will have either charge-charge attraction or
repulsion at the e and g positions, depending on pH. In the case of the Helix in 7 and 13.
it would be expected that the interactions of the ionized glutamic acid sidechains would
destabilize the a-helix and reduce the amount of interchain helical-helical association.
The opposite would be true for the lysine-glutamic acid interactions at the c and g
positions. These latter interactions are believed to be minor contributors to the helical-
helical stabilization because there are almost twice as many acid-acid interactions as
there are acid-base interactions. Isoelectric point measurements indicate that a negative
charge excess would exist at pH >5.7 for 7 and pH > 5.5 for 13.
The secondary structures of the target proteins (5 \M) in aqueous salt solutions
(pH 7.4, 10 mM Na2HP04, 1 50 mM NaCl) were determined by circular dichroism
spectroscopy (CD) over the wavelength range 195-250 nm (Fig. 3.3). The results show
that 9 is predominantly random coil, as evidenced by the minimum in mean residue
ellipticity at 201 nm. The CD scans of 7 and 13 have the characteristic a-helical amide
transitions at 222, 208, and 190 nm. Methods for analyzing protein secondary structure
in solution with circular dichroism spectroscopy have been reviewed by Greenfield (34).
The accuracy in predicting specific protein conformations from test data depends upon
the mathematical method used as well as the protein basis spectra chosen for each
method. The CD spectrum of each protein in Figure 3 .3 was analyzed by three different
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methods: ridge regression, neural networks, and self-consistent method (described in the
Experimental Section). The results of these methods are reported in Table 3. 1 in
addition to the expected a-helical conformational values. The expected a-helical content
is calculated from the number of amino acids in the Helix region divided by the total
number of amino acids in the protein. For protein 7 the "measured" (fit) a-helical
content is within 20% of the predicted value while for 9 and 13 the values are within
10%. Both the ridge regression and neural network analyses predict higher a-helical
contents for 7 and 13 than the self-consistent method. These data suggest the helix may
propagate further into the chain than would be expected. In any case, it appears that the
helicity of the coiled-coil domains of the triblock is not reduced by introducing the
disordered coil regions between helical ends.
Percent of a, p, and random conformations present in 5 nM solutions of
7, 9, and 13.
Protein Algorithm (X P random error* predicted (x**
7 ridge regression 0.64 0.19*** 0.17 0.008 0.55
7 neural network 0.78 0.01 0.21 0.227 0.55
7 self-consistent 0.60 0.16*** 0.23 0.001 0.55
9 ridge regression 0.06 0.75*** 0.20 0.013 0.00
9 neural network 0.06 0.44 0.50 0.182 0.00
9 self-consistent 0.08 0.64*** 0.28 0.004 0.00
13 ridge regression 0.41 0.35*** 0.24 0.022 0.37
13 neural network 0.47 0.14 0.39 0.182 0.37
13 self-consistent ()..35 0.35*** 0.31 0.002 0.37
* Errors are averaged over a, P, and random confomiations and arc reported as variance for ridge regression,
Standard deviation for self-consistent, and mean error for neural network.
** Values calculated from number of amino acids in the helical region divided by the total number of amino
acids in the chain.
*** Value includes calculations Ibr both (i-sheet and (^-lum.
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are
Gelation through physical crosslinking requires association of the coiled-coil
elements of the tnblock. In order to determine whether the unfolding behavior of the
helical end blocks is affected by attachment of the coil domain, the pH dependence of the
transition temperature, T„, was measured for both 7 (5 ^M) and 13 (5 ^M) in solution.
The similarity of the unfolding processes is shown in Figure 3.4 and in Table 3.2. At pH
values greater than 10, the unfolding transitions of both 7 and 13 occur between 30 and
40^. The low T„. is expected in basic solution in which the glutamic acid residues
deprotonated and charge-charge repulsion of the helices will occur. In addition, the
helical content at 0 X is reduced from 22055 (pH 7.6) to 16835 (pH 11.5) deg cm'
dmor' for 7 and from 13722 (pH 7.6) to 10294 (10.8) deg cm' dmof' for 13. This
would imply that the individual helices are partially unfolded at highly basic conditions
and low temperatures. When the pH is lowered to values between 7 and 10, the Tn,
values increase slightly but are within 10 X of each other. In the range ofpH 7-10 and
lower, the lysine (pKa =10) is charged and can form interhelical salt bridges with the
glutamic acid. Upon further decrease ofpH to 6, the T^ for 7 and 13 occurs at 88T and
8 rc respectively. At pH 5 and lower, no transitions are observed for either protein at
temperatures below 100 "C and the helical content decreases only slightly throughout the
0-100 °C temperature range. Acidic conditions effectively stabilize the helix so that no
thermal denaturation of 1 or 3 is observed.
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Table 3.2 m values as a function ofpH for proteins 7 and 13.
P^rotein
7
7
7
7
7
7
13
13
13
13
13
pH
6.1
6.9
7.6
9.4
10.7
11.5
6.1
6.9
7.6
9.5
10.8
Tm(T)
88
64
51
50
40
31
81
55
54
49
31
[9]::: 0 X
21385
22143
22055
21979
20674
16835
14218
14125
13722
11888
10294
The thermal denaturation experiments described above were measured in
solutions containing 150 mM NaCl. There have been many observations and discussions
about the effect that NaCl has on the stability of coiled-coil interactions in solution (39-
43). The most important observation is that while the addition ofNaCl ( > lOOmM) has
no significant effect on coiled-coil stability at neutral pH, the stability of the coiled-coil
increases drastically in acidic environments (43). Similar behavior was observed for the
helical domains in this study. Experiments show that a T^ is observed for protein 7 at
85 T in 10 mM Na2P04, pH 2. 1 (without NaCl). No thermal transitions at 222 nm are
observed from 0 to 100 T for either 7 or 13 at pH 2. 1 . The lack of a thermal transition
at before 100 °C suggests that the helices are stabilized with the addition ofNaCl in
acidic environments. It is our intent to investigate the solution behavior of 7 and 13
under physiological conditions and therefore, the addition ofNaCl should not
significantly affect the thermal stability of the helices in the neutral pH range.
The concept of reversible gelation as a function ofpH in this work is based on the
separation of charge along the backbone of the triblock protein. For instance, if the
100
protein chains are in a low pH solution, the sidechain glutamic acids would be
protonated, resulting in an increased stability of the coiled-coil regions. Precipitation
would occur because highly associated oligomer states of the helical domains can be
formed. The coil domain would also have protonated acids which would cause it to
collapse to a hydrophobically packed globule. As the pH of the solution increases,
deprotonation of the glutamic acids in the coil domain would allow swelling of the
flexible spacer while some deprotonation of the acid groups in the helical domain would
not disrupt the helical-helical packing. The protein would behave as a noncovalent
gelled network where the reversibility with temperature in the gelled state results from
thermal dissociation of the leucine zippers regions. Finally, if the gelled solution is
increased to a high enough pH, all of the glutamic acids become deprotonated in the
helical domains. This decreases the state of association of the helices so that the proteins
flow as the chains are free to slip past one another. This proposed gelation process is
depicted in a general schematic in Figure 3.5.
The solution data serve as guidelines for obtaining the conditions for gelation. In
these experiments, T,„ values over 37"C are of interest because the applicability of using
this gel as a delivery vehicle in the body or for application on the body will require that
the material is not affected at body temperature. In order to investigate the pH and
temperature dependence of gelation, dynamic light scattering experiments were done.
Diffusing wave spectroscopy (DWS) (44-48) was used to measure the viscoelastic
behavior of 13. The measurement obtained is the dynamic intensity auto correlation
function of light that is multiply scattered from a suspension of tracer particles (0.3 jim
sulfonated polystyrene latexes). The calculation of the autocorrelation function in DWS
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requires two approximations to be made The llrst approximation is that as light
propagates through a highly scattering medium, each photon is scattered a large number
of times. The propagation oflight is described by the dilTusion approximation where all
interference effects within the medium are neglected and the phases of all photo.is are
completely randomized (47), The second approximation is that the conservation of
scattering momentum at every point along the full path can be neglected and therefore,
the individual scattering events are approximated by the contribution of an average
scattering event (48).
From the autocorrelation function, the time average mean-square displacement of
the tracer particles as a function of time is determined. In addition, the shear creep
compliance can be obtained with the following relationship (49),
J(t) = (Tca/ kT) <r'(t)> {2}
where a is the radius of the bead and <r^(t)> is the average mean square displacement of
the beads (yim^).
For a viscous liquid, the correlation function is a decreasing, convex function of
time while for an elastic medium, there is a plateau in the correlation function (49). A
viscoclastic medium will show some aspects of each limiting behavior The correlation
function was measured for protein 13 (5% (w/v), 10 mM Tris bulTer, 25"C) at pi I 8.0,
8.8, and 9.5 (not shown). The corresponding mean square displacement curves are
shown in Figure 3.6. These data suggest that the gel point lies between pi I 8.0 and 9.5.
At pH 8.0, 13 is an elastic gel, at pll 8.8, a viscoclastic gel, and at pll 9.5, a viscous
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liquid. The elastic behavior in these curves is shown in the plateau region over time
scales of 1 x 10"^o 1 sec. The plateau region reflects that the mean square displacement
of the tracer particles is relatively small during this time scale. In an elastic medium,
particles will not move very far from their starting points. On the other hand, the tracer
particles are not hindered in a viscous fluid and the mean square displacement will grow
with time.
The thermal dependence of gelation for 13 was recorded by cycling a 5% gel
through a series of temperatures ranging from 23 "C to 55 X at pH 7.8. The average
mean square displacement versus time at various temperatures is plotted in Figure 3.7.
These data were acquired in the following temperature order: 23, 39.6, 47.7, 55.2, 42.7,
24.9 and 23 °C. These data show that as the temperature is increased to 55T, the gel
becomes a fluid. An interesting observation in the thermal analyses is the hysteresis that
occurs after the material is heated to 55 "C and returned to 23 T (Figure 3.8). Most
likely, there is some time-dependence for the helices to re-fold into the original
associated state. The two to three hour equilibration times allotted between six hour
experiments might not have been long enough for the gel to return to its native state.
The dependence of gel formation as a function of concentration was also
investigated for 13 at pH 7.9. The DWS results show that 13 becomes a fluid at 3%
(w/v) whereas at 5%, 13 is an elastic medium (Figure 3.9). The 4% sample responds as
a viscous liquid at early times but at intermediate times, the emergence of a plateau is
apparent. Therefore, the critical concentration for forming an elastic gel that spans the
entire volume of interest is between 4-5%. When concentrations are between 3-4%. the
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protein is most likely forming soluble aggregates that viscosily the solution by increasing
the apparent molecular weight.
The pH, temperature, and concentration behavior of 13, as determined by DWS
experiments, indicates that these materials are not simple gels. At very short times
(t < 10-^ sec), the correlation function, thus average mean square displacement, for any
of the above experiments does not give any information about the gel behavior. The
tracer particles are probing very short length scales and local fluctuations at these times.
On the other hand, viscous-like behavior is observed for all of the experiments in the
very long time limit. The existence of a plateau in the correlation function provides
evidence for gel behavior at some range of times. With further experiments, this time
range will be evaluated.
The contribution of the disulfide linkage to gelation was investigated for protein
13 where one C-terminus cysteine exists on each protein chain. The fraction of free thiol
in a solution of 13 was determined by the Ellman reaction (50). A linear increase in
absorbance with increase in concentration was observed for the control,
P-mercaptoethanol. With 13, no change was observed in absorbance as the
concentration of protein was increased. This suggests that 13 is fully oxidized in
solution under physiological conditions. It is then expected that the thiol groups remain
oxidized in the conditions used to prepare gels of 13. Introduction of 10 mM P-
mercaptoethanol into a 5% (w/v) gel does not cause dissolution of the gel; therefore, it
can be concluded that the disulfide linkage of the protein chains are not responsible for
gelation.
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From the previous discussion, the driving force for gelation is believed to be the
non-covalent association of a-helical coiled-coil end blocks that contain both
hydrophobic and electrostatic attractive forces. The formation of the gel of protein 3 can
be made at concentrations greater than 4%(w/v), In the gelation process, there are two
separate reversibility issues to consider; one with pH and one with temperature. This
reversible process results from the pH dependent electrostatic interactions of the a-
helices as well as extension and contraction of the disordered coil domain. The
thermoreversibility of gelation depends on the energy needed to break the non-covalent
hydrophobic and electrostatic interactions.
In most synthetic polymer systems, such as acrylamide, methacrylate, or cellulose
derivatives, the gel behavior and solubility of the system is an additive function of the
side groups (51). The solubility behavior of the protein described in this work is most
likely dominated by secondary structure. This statement is based on the fact that the
helix-coil transition depends on temperature as well as pH and this is what drives the
solubility-induced transitions seen in the gel of 13.
3.5 Conclusions
It has been shown that genetic engineering principles can be applied to the
synthesis of a protein-based materials that have defined structure and function. The
triblock protein, 13, forms an elastic physical gel at physiological pH and temperature
conditions whereas the control protein blocks do not. The advantages of the triblock
design are that different coiled-coil domains of various stabilities can be introduced as
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the physical crosslinks and the flexible spacer can be shortened or lengthened to have
precise control over the pore size of the gel. The charge density of the flexible spacer
can also be changed in order to compare solubility as well as swelling behavior. These
are future directions that are currently being pursued in our group.
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MRGSHHHHHHGSDDDDKWA- Helix
-IGDHVAPRDTSMGGC
MRGSHHHHHHGSDDDDKASYRDPMG- [(AG)3PEG]^q
-ARMPTSW ( 9 )
MRGSHHHHHHGSDDDDKWA- Helix -IGKHVAPRDTSYRDPMG- [(AG)3PEG]
^ ARMPTSGD- Helix -IGDHVAPRDTSMGGC (13)
Helix = SGDLENEVAQLEREVRSLEDEAAELEQKVSRLp^IEDLKAE
Figure 3.1 Amino acid sequences of the three proteins studied. (7) consists of 76
amino acids of which 42 are of the leucine zipper, Helix. (9) consists
of 122 amino acids where 90 amino acids are of the alanylglycine repeat,
[(AG)3PEG]io. (13) consists of 230 amino acids of which 84 are of the
Helix repeat and 90 are of the alanylglycine repeat. Charge patterns in
the e and g positions of the Helix heptad repeat, {abed efg )^ are
underlined. Abbreviations for the amino acids are: A, Ala; C, Cys;
D, Asp; E, Glu; F, Phe; G, Gly; H, His; I, lie; K, Lys; L, Leu; M, Met;
N, Asn; P, Pro; Q, Gin; R, Arg; S, Ser; T, Thr; V, Val and W, Trp.
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Figure 3.2 Reversed phase high performance liquid chromatograms of genetically
engineered proteins. (A) 7 (76 |.ig) eluted at 26.76 minutes (B) 9 (54
lag) eluted at 19.36 minutes. (C) 13 (54 eluted at 27.33 minutes.
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Figure 3,3 Secondary structural analyses using circular dichroism spectroscopy.
(A) 9 (5 fiM). (B) 13 (5 |.iM). (C) 7 (5 laM), Spectra were recorded
at 25T in 10 mM NaHzPOa, 150 mM NaCl, pH 7.4 (upon addition of
1 N NaOH).
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Figure 3.4 Thermal melting transitions of 7 (5 |iM) and 13 (5 ^iM) monitored at
222 nm as a llinction of pH. Measurements were made in 10 mM
NaH2P04, 1 50 mM NaCl (pH 7.6). was determined by taking the first
derivative of the CD signal [9]222 with respect to temperature ' (K) and
finding the minimum of this function.
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Figure 3.6 Mean square displacement as a function of time in a linear-log
representation for 5% (w/v) of protein 13 in 10 mM Tris buffer
at pH8.0, 8.8, and 9.5.
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Figure 3 .7 Mean square displacement as a flinction of time at temperatures 23 "C to
55 "C for protein 13 (5% (w/v), 10 mM Tris butTer, pH 7,8). (a) signifies
data collected upon heating the sample from 23 "C to 55.2 "C and (b)
signifies the data collected on cooling the sample from 55.2 "C to 23 "C.
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Figure 3 .8 Mean square displacement as a function of time for 13 at temperatures
(a) 23 °C before thermal cycling and (b) 23 "C after thermal cycling.
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Figure 3.9 Concentration dependence of the mean square displacement as a function
of time for 13 at pH 7.9 and 23 "C.
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CHAPTER 4
INCORPORATION OF 5',5',5'-TRIFLUORO-L-LEUCINE AT THEHYDROPHOBIC INTERFACE OF LEUCINE ZIPPERS
4. 1 Objectives
The stabilization of coiled coil structures is believed to be modulated by
interactions between regularly spaced hydrophobic and charged groups that are on
adjacent associated helices. In particular, it is believed that the hydrophobic residues at
the a and d position in the general heptad repeat, {a b cdefg\, determines the global
folding of the helices while the polar groups at positions e and g stabilize the helices
through salt bridges. To evaluate the effect of substitution of the hydrophobic residues
at position c/, an unnatural amino acid analogue, 5',5',5'-trifluoro-L-leucine (Tfl), was
incorporated in place of leucine (Leu) in the recombinant leucine zipper coiled coil
proteins, Recognins A 1 (A 1 ) and B 1 (B 1 ) (Figure 4. 1 ). An investigation of the
incorporation of Tfl into the recombinant proteins with bacterial hosts auxotrophic for
leucine will be presented. Also to be discussed is the isolation of the Tfl containing
chains and the effect of Tfl incorporation on the thermal stabilities of the interacting a-
helices.
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4.2 Introduction
The incorporation of non-natural amino acids into protein-based materials is one
way to introduce new chemical functionality and physical properties into natural polymer
systems. The syntheses of these kinds of materials provide an opportunity to explore
biological changes or activities that result from the substitution of non-natural amino
acids for natural ones (1-3) and to study unique structural and ftinctional properties that
are associated with these materials. Amino acid analogs can be introduced into cellular
proteins either by direct incorporation during protein synthesis or by post-translational
modification. Overall, there are three pathways to incorporate non-natural amino acids
into proteins: in vivo biological synthesis (4), in vitro chemical and biological synthesis
(5-13), and chemical synthesis by solution or solid-phase methods (14, 15). There has
been an ongoing research effort in our group to utilize the in vivo biological synthetic
route to incorporate non-natural amino acids into polymer chains (16-21)
.
One non-natural amino acid that is incorporated into E. co/i proteins in the
absence of its natural analog (1) is 5',5',5'-trifluoroleucine (2) (22-24) shown below.
Fluorine mimics the geometry of hydrogen (van der Waals radii of fluorine 1 .35A to
hydrogen 1 .2A) while differing in chemical character (electronegativity of fluorine 3 .98
versus 2 .2 for hydrogen). The lipophilic nature of the trifluoromethyl group makes it an
ideal candidate for the modification of membrane spanning or hydrophobically
associating proteins. Tfl imparts unique chemical and physiological stability to the non-
natural amino acid containing proteins (25, 26) while the fluorine atom can be used in ''^F
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NMR to monitor stmc.ural changes in proteins (27) or to study the motion of fluorinated
proteins within lipid bilayers (28).
CF
OH
O
Leucine (Leu)
1
OH
H2N
O
5',5',5'-Trifluoroleucine (Tfl)
One class of proteins known to associate through hydrophobic interactions are
the coiled-coil proteins (29). These proteins contain a seven amino acid repeat, {ahcd
^fg)n, where the a and d positions are non-polar amino acids, with J being mostly
leucine. The result of this 3-4 hydrophobic repeat is a characteristic Ij a-helix where the
a and d positions align on one face of the helix so that it can hydrophobically associate
with adjacent helices. Coiled-coil proteins are good candidates for structural
modification since they are found in over 200 proteins in the body and are involved in
many recognition processes (30). Their roles range from gene regulation such as the
yeast transcription factor, GCN4 (31), to membrane fusion and infection processes of
human immunodeficiency virus type I (32). The substitution of leucine (Leu) with
5',5',5'-trifluoroleucine (Tfl) in coiled-coils would be one way of modifying residues that
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are believed to be the driving force for the association of a-helices through hydrophobic
interactions (33, 34).
Coiled-coil proteins being used for the incorporation of Tfl are shown in Figure
4. 1
.
These proteins were prepared through genetic engineering techniques and were
designed to form stable water soluble coiled-coils with leucines at every position as
found in the Jun oncogene protein (35). An algorithm developed by Lupas et al. (30)
was used to identify the most probable amino acids positioned at a, b, c, and / found in
naturally occurring coiled-coils. The sequence of amino acids at these positions were
also chosen based on their ability to increase water solubility of the chain and to make
the corresponding DNA manipulations easy. Acidic or basic groups, glutamic acid and
lysine, were placed at the e and g positions to provide intermolecular attraction or
repulsion of chains at varying pH.
The incorporation of Tfl into the helical chain at the J position of the heptad
repeat, which normally encodes leucine during protein synthesis, was accomplished by
using a leucine auxotrophic strain ofE. coli and media shifting techniques developed by
Kothakota et al. (19). We rationalized that by modifying the a-helical hydrophobic face
with trifluoromethyl groups we would be able to increase the stability of the interacting
helices in solution. This work reports the syntheses of Tfl chains Al and Bl containing
a population of eight possible Leu position being substituted. The level of Tfl
incorporation and initial thermal stability measurements of the a-helices will be
discussed.
122
4.3 Experimental Section
4.3.1 Materials
5',5',5'-Trifluoroleucine (mixture of stereoisomers) was purchased from MTM
Research Chemicals (Windham, NH). Leucine auxotrophs of strain mclOOO (F"
lacAx74anaD139/(Ana Abioc-leu)A7679 gal U gal K rspL) containing pREP4 plasmid
{Qiageri^^, Chatsworth, CA) were obtained from Professor Fournier's Lab, Department
of Biochemistry and Molecular Biology (University of Massachusetts, Amherst). The
stable auxotroph is designated JM-1. Expression vectors containing Al and Bl DNA
sequences (pQE9-Al and pQE9-Bl) were obtained from the U.S. Army Natick RD&E
Center (Natick, MA).
4.3.2 General Methods
Electrospray mass spectra were collected on a Fisons VG Platform II™
electrospray mass spectrometer. Al and Bl protein spectra were also recorded as
standards. All samples were run in 50:50 acetonitrile:water with 0.2% formic acid at 12
pmol/)j.L concentrations. Data was recorded with a positive ion mode (full scan 600-
1 500 m/z), an infusion rate of 5|j,L/min, and cone vohages of either 35 or 50 V. A
Waters^^ high performance liquid chromatography (HPLC) system (7 1 7 plus
Autosampler, 486 Tunable Absorbance Detector, and 600 Controller) was used to inject
50 \xL samples at flow rates of 1 mL/min onto a Vydac^^ C 1 8 reversed phase column.
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Millenium-^^ software was used in the analysis of the collected spectra. Detection at
210 nm was accomplished over a 60 minute gradient of water/0. 1% trifluoroacetic acid,
TFA to acetonitrile/0. 1% TFA. This gradient consisted of 90: 10 (10 min), 50:50 (20
min), and 100:0 (30 min). Amino acid analysis was performed by the Analytical
Chemistry and Peptide/DNA Synthesis Facility at Cornell University, Ithaca, NY.
Amino acid analysis was carried out on a Pico-Tag Amino Acid Analysis System (36).
Duplicate samples were hydrolyzed in constant boiling HCl at 150 T for 1 10 min.
Appropriate blanks, controls and standards were hydrolyzed in the same vessel as a batch
hydrolysis. The amino acids were derivatized with PITC and analyzed by reversed phase
HPLC (37, 38). The resulting phenylthiocarbamoyl amino acid derivatives were
separated on a 4.6 x 300 mm Nova Pack CI 8 column employing a modified Pico-Tag
buffer system. Circular dichroism spectra were recorded on an Aviv 62DS
spectropolarimeter (Lakewood, NJ). Mean residue molar ellipticity reported at 222 nm
([Q]222, deg cm dmol" ) was calculated from the following equation: [9] = [9]obs x
MRW/(c X 1), where [0]obs is ellipticity measured in millidegrees, MRW is the mean
residue molecular weight or the molecular weight of the peptide divided by the number
of amino acid residues, c is the peptide concentration in g/L determined by quantitative
amino acid analysis, and 1 is the optical path length in mm. Thermal melting curves were
determined by monitoring the CD signal of the protein solutions (3 |_iM) at 222 nm as a
function of temperature. Data was collected from 0 to 90 "C in 1 "C increments with an
equilibration time of 1 minute. Spectra were collected in 50 mM sodium phosphate
buffer, 100 mM NaCl, pH 7.4. Two Peltier units on both sides of the 1 cm path length
rectangular cell (Helma) were used to regulate the temperature to within ±0.2 "C. A two
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state mechanism was used to describe the equilibrium between folded and unfolded
protein states. From this two state model, thermal melting temperature, T.,„ was
calculated as the temperature at which 50% of the helix is unfolded. To get this value,
ellipticity readings were normalized to the fraction of the protein folded using the
standard equation:
fn = ([e]-[e]u)/([0]n-[e],) li)
where [GJn and [0]^ represent the ellipticity values for the fully folded and fully unfolded
species, respectively, at 222 nm. All thermal melting transitions were determined to be
reversible (± 2 "C) with 96% (Al), 88% (Bl), 99% (Tfl Al), and 97% (Tfl Bl) of the
initial helix contents recovered.
4.3.3 Protein Expression and Purification
PQE9-A1 and pQE9-Bl were used to transform strain mclOOO (F"
lacAx74anaD139/(Ana Abioc-leu)A7679 gal U gal K rspL) containing pREP4 to yield
JM-l/pQE9-Al and JM-l/pQE9-Bl
. Single colonies of cells were grown to saturation
in 5 ml of 2xYT medium (16 g Bacto-Tryptone, 10 g Yeast Extract, 5 g NaCl per liter)
containing ampicillin ( 200 ng/ml) and kanamycin (25 |ag/ml) overnight at 37"C. Each of
these cultures was transferred to 1 L of sterilized YT medium containing the same
concentrations of antibiotics. The cells were incubated until optical densities (600 nm)
of 1 were reached and then centrifuged at 5000 rpm for 10 minutes. The supernatant
was then decanted and the cells were washed with 1 L of \% M9 salt solution (60 g
Na2HP04, 30 g KH2PO4, 5 g NaCl, 10 g NH4CI per liter). Again the cells were pelleted
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and resuspended in 2L ofM9 medium (10% v/v M9 salt solution, 10% 19 amino acid
solution (0.4 g of each amino acid, except leucine, per liter), 0.1% MgS04 7H20 (IM),
0. 1% CaCl2 (O.OIM), 0. 1% vitamin B,, 4% glucose (20% w/v solution), 0.33%
ampicillin (200 ^g/ml), 0.16% kanamycin (25 ^ig/ml) and 75.3% distilled deionized
water). Leucine (40 mg/mL
,
final concentration of 40 \ig/mL) or 5',5',5'-trifluoro-
D,L-leucine (40 mg/mL ; final concentration of 40 \xg/mL) was added in addition to the
M9 medium. The cells were grown for 15 minutes before isopropyl-p-thiogalactoside
(IPTG, ImM) was added to induce protein synthesis. Cell cultures were removed and
centrifuged at 5000 rpm for 10 minutes at various times after induction with IPTG. All
pelleted cells were resuspended in 25 ml of lysis buffer (6 M guanidine HCl, 0. 1 M
Na2HP04, pH 8) and placed in -80 X freezer overnight. The supernatants from the cell
lysates were subjected to nickel(II)-NTA metal affinity chromatography. The collected
protein fractions were frozen at -80°C and lyophilized to give total dry weights for all
proteins of 75-100 mg per liter of growth medium.
4.4 Results and Discussion
DNA encoding the leucine zipper proteins was first introduced into bacterial
hosts auxotrophic for leucine. Expression of Al and Bl was carried out by shifting the
growth medium to minimal medium containing 19 or 20 amino acids prior to induction
with isopropyl-P-thiogalactoside. Figures 4 .2 and 4 .3 show the results of the protein
expressions in media lacking Leu and Tfl, in the presence of Leu but not Tfl, and lacking
Leu but enriched with Tfl. Prior to induction there is no protein accumulation but one to
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three hours after induction, cells in medium containing either Leu or Tfl showed protein
expression. The calculated masses for Al and Bl are 8305 and 8299 respectively.
Relatively broad bands are found on the polyacrylamide gels for both proteins; Al
migrates between molecular weights of 6200 and 14000 of the standard protein marker
and Bl migrates at approximately 6200.
Substitution of Tfl for leucine in Al and Bl was confirmed by electrospray mass
spectrometry (39, 40) and the resuhs shown in Figures 4.4-4. 13. Increases in the
population of Tfl substitution was monitored as a function of time after protein
induction. Proteins were isolated and purified with Ni'' metal affinity chromatography at
1, 2, 3, and 4 hours after induction. Figures 4.4 and 4.5 are the electrospray results for
Al and Bl, respectively, grown in Leu (40 }ig/ml) supplemented medium for 4 hrs, and
Figures 4.6-4. 13 are the results for Al and Bl grown in Tfl (40 i^g/ml) medium over 1 to
4 hrs.
The mass spectra shown in Figures 4.4 and 4.5 contain [M+H]' peaks at 8306.25
and 8300.45 that correspond to calculated masses of 8305 and 8299 for Al and Bl
proteins respectively. In addition, a peak appears at a [M+H]' that is +14 mass units
higher than the calculated average mass for either protein. This corresponds to a single
methylation reaction and it is believed that this reaction is a post-translational event
where the N-terminal methionine is being methylated (41-43). N-monomethyl-
methionine has been found in several proteins and the levels of methylation reported in
literature are in the range of 30-50% (44). Specifically, a protein sequence that can
trigger methylation in proteins expressed in E. coli is an N-terminal methionine followed
by a basic residue (Lys or Arg) in the second position. Both Al and Bl proteins have
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MetArg as the first two ammo acids that are translated and therefore seem likely to be
methylated based on prior literature. A mass peak at 8343 found in both Al and Bl
protein spectra corresponds to a chain that has a formylated methionine at the N
terminus and the mass peak at 8278 in Figure 4.4 is unassigned.
In Figures 4.6-4.13, a population of peaks, approximately 54 mass units apart,
appear in the spectra of proteins expressed in Tfl enriched medium. The substitution of
one Tfl for one Leu corresponds to a mass increase of 54. These peaks confirm that
eight Leu positions in the protein chain are being substituted with Tfl over time. The
chains free of Tfl are believed to result from the fact that the cells first use trace amounts
of leucine left in the growth medium for protein translation.
Reversed phase high performance liquid chromatography (RPLC) was used to
separate the Tfl-substituted chains from the unsubstituted chains (Figures 4. 14 and 4. 15)
and was used to monitor the relative amounts of substitution during protein syntheses
when the concentration of Tfl was varied from 4 ng/ml to 32 |ig/ml (Table 4. 1). On
reversed phase columns, C8 groups are known to disrupt interchain association of
coiled-coil proteins without denaturing the a-helices (45). The exposed non-polar face
of the helix readily partitions into the hydrophobic stationary phase at a retention time
dependent on hydrophobicity at that face. It has been observed that the substitution of
valine and isoleucine for leucine at the d position results in retention times that are
shorter than those observed for the leucine containing chains (46).
Substitution of Tfl for Leu at various d positions along the Al and Bl chains
results in broad peaks that elute at longer retention times than the relatively narrow
peaks of the unsubstituted chains. Figures 4.14 and 4.15 show elution profiles for Al
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(HPLC purified), Al (NP^ purified), Tfl Al (Ni^ ) and Bl (HPLC purified), Bl (Ni^^
purified), and Tfl Bl (Ni^') respectively. The broad peaks eluted at retention times of
35.22-36.50 min for Tfl Al and 3 1 .48-32.79 min for Tfl Bl are assigned as the Tfl
populations. It was this population that was isolated with RPLC for the amino acid
analyses and thermal denaturation experiments described below.
In order to assess the dependence of protein synthesis on the concentration of
Tfl, varying levels (4 to 32 ^g/ml) of Tfl were added to the cell growth medium. Table
4.
1 describes the extent of Tfl incorporation with varying Tfl concentrations. An
exponential skim was used to resolve the narrow peak from the shoulder of the broad
peak. The relative area of the narrow peak to the total area was used as a qualitative
measure of the extent of Tfl incorporation. It is shown that by increasing the total Tfl
concentration from 4 ng/ml to 32 |^g/ml, the amount of Tfl incorporated is increased as
evidenced by the increase in the area of the broad peak.
Table 4. 1 Extent of Tfl incorporation with Tfl concentration in growth medium.
Sample Concentration of Fraction of
Tfl (^g/ml)" Leu Chains (%)''
Tfl Al 4 100
THAI 8 14
THAI 16 12
TflAl 32 7
TflBl 4 100
Tfl Bl 8 N/A
TflBl 16 12
TflBl 32 10
" The amount of Tfl is the final concentration in the cell growth medium.
* Relative area of narrow peak, corresponding to fully leucinated chains, to total area.
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were
Amino acid analyses were performed on Tfl Al and Tfl Bl populations that
isolated and purified by reversed phase HPLC. Comparison of the percent leucine
content suggested 66% and 3%% levels of Tfl substitution for Al and Bl respectively
(Tables 4.2 and 4.3). Initial measurements of thermal stabilities of a-helical Leu and Tfl
containing Al and Bl were made by circular dichroism spectroscopy (Table 4.4 and
Figure 4. 16). Thermal stabilities of the Tfl-substituted helices recorded at 222 nm were
higher than those of the corresponding Leu-substituted helices by 8T and 13°C
respectively. These data suggest that the increase in hydrophobicity caused by the
substitution of trifluoromethyl for the methyl group at the 5-position of leucine causes an
increased stability of the a-helix for both Al and Bl.
Amino acid compositional analysis of Recognins Al and Tfl Al
.
mol % mol % mol %
amino acid (theor) (obs) Al (obs) Tfl Al
aspartic acid +
asparagine 12.2 12.5 12.4
glutamic acid +
glutamine 17.6 18.4 18.9
serine 8.1 8.3 8.7
glycine 6.8 7.1 7.7
histidine 8.1 8.1 7.3
arginine 8.1 7.9 7.6
threonine 1.4 1.5 1.5
alanine 9.5 9.4 10.2
proline 1.4 1.7 1.5
tyrosine 0.0 0.1 0.2
valine 4.1 3.7 4.1
methionine 2.7 2.3 2.7
cysteine 0.0 0.1 0.1
isolcucine 4.1 3.5 3.7
leucine 10.8 9.7 3.1
phenylalanine 0.0 0.1 0.2
lysine 5.4 5.6 10.2
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Amino acid compositional analysis of Recognins B
1
amino acid
aspartic acid +
asparagine
glutamic acid +
glutamine
serine
glycine
histidine
arginine
threonine
alanine
proline
tyrosine
valine
methionine
cysteine
isoleucine
leucine
phenylalanine
lysine
12.2
9.5
8.1
6.7
8.1
8.1
1.4
9.5
1.4
0.0
4.1
2.7
0.0
4.1
10.8
0.0
13.5
12.0
9.9
8.3
7.2
7.7
8.0
1.4
9.7
1.5
0.1
3.9
2.2
0.1
3.8
10.9
0.0
13.2
12.8
10.5
8.9
7.9
8.4
8.2
1.6
9.5
1.4
0.1
3.3
2.2
0.3
3.6
7.1
0.1
14.0
Table 4 4 Thermal melting transitions ofA 1 , Tfl A 1 , B 1 , and Tfl B
1
monitored at 222 nm.
Dimer Complex T^ in PBS {Xy
Al-Al 58
Tfl Al-Tfl Al 66
Bl-Bl 75
TflBl-TflBl 88
Tn, = temperature at which 50% of the heli.x is unfolded in
50 mM sodium phosphate, 100 mM NaCl, pH 7.4.
These results raise an important question about the relative stabilities of the Al
and Bl proteins. Why does 66% replacement of leucine with trifluoroleucine in Al only
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result in an 8 °C increase in T„ whereas a 38% replacement in Bl results in a 13 »C
increase in T„? One possible explanation is that an increased level of Tfl will destablize
helical-helical interactions due to the increased size of fluorine over that of hydrogen and
to the difference in chemical character between fluorine and hydrogen. The introduction
of Tfl at the c/ position in the heptad repeat could disrupt the overall packing of coiled-
coils. At lower levels of Tfl substitution, the effect of increased size and
electronegativity on the packing density might be less significant than at higher levels. It
is speculated that at near complete Tfl substitution at the d position the helices would be
very stable due to favorable fluorine-fluorine interaction. The interaction between
fluorine and hydrogen is not favorable and thus at intermediate levels of Tfl substitution,
the helices would be destabilized. Eventually, we would like to optimize this system so
that a relationship between Tfl substitution and thermal stability can be developed.
4.5 Conclusions
An in vivo synthetic strategy is established for the incorporation of 5',5',5'-
trifluoroleucine at the Leu positions of recombinant coiled-coil proteins, Al and Bl.
The results demonstrate that coiled-coils become more thermally stable with relatively
low levels of Tfl substitution. The use of leucine auxotrophs to prepare unique coiled-
coil proteins containing Tfl groups can be applied to a variety of proteins where Leu
participates in folding, stability, activity, or fianction. With optimization of this strategy,
the enhancement of certain physical properties in natural polymer systems can be
achieved for biological or materials applications.
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N" MRGSHHHHHHGSMA-7/e//x-IGDLNNTSGIRRPAAKLN C
= SGDLENEVAQLEREWSLEDEAAELEQKVSRLKNEIEDLKAE = Al
Helix = SGDLKNKVAQLKJlKVRSLp)KAAELKQEVS - Bl
Figure 4. 1 . Amino acid sequences for recombinant leucine zipper proteins,
Al and Bl. Eight leucine positions in each chain (bolded) can
be substituted with Tfl. Charge patterns in the e and g positions
of the Helix heptad repeat, (a b c d efg)^, are underlined.
Abbreviations for the amino acids are : A, Ala; C, Cys; D, Asp;
E, Glu; F, Phe; G, Gly; H, His; I, lie; K, Lys; L, Leu; M, Met;
N, Asn; P, Pro; Q, Gin, R, Arg; S, Ser, T, Thr, V, Val; and W, Trp.
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-Leu +Leu +Tfl
Time (Min) after
induction 0 60 120 180 0 60 120 180 0 60 120 180
Marker
43 kD
29 kD
18.4 kD
14.3 kD
6.2 kD
3.4 kD
2.3 kD
Figure 4.2 In vivo synthesis of Recognin Al after culture was shifted
to minimal medium supplemented with amino acids. The lanes
are indicated as follows: Lane 1, low molecular weight marker;
lanes 2-5, medium lacking both leucine and Tfl; lanes 6-9,
medium containing leucine (40 |ig/ml) but lacking Tfl; and lanes
10-13, medium lacking leucine but containing Tfl (40 |ig/ml).
Protein accumulation was monitored for three hours after
induction with IPTG (1 mM) and was visualized on a 15% SDS-
polyacrylamide gel with Coomassie Brillant Blue R-250.
134
-Leu +Leu +Tfl
Time (Min) after
induction
43 kD
29 kD
18.4 kD
14.3 kD
6.2 kD
3.4 kD
2.3 kD
Marker
0 60 120 180 0 60 120 180 0 60 120 180
i Hi tl'
Figure 4.3 In vivo synthesis ofRecognin Bl after culture was shifted
to minimal medium supplemented with amino acids. The lanes
are indicated as follows: Lane 1, low molecular weight marker;
lanes 2-5, medium lacking both leucine and Tfl; lanes 6-9,
medium containing leucine (40 )ig/ml) but lacking Tfl; and lanes
10-13, medium lacking leucine but containing Tfl (40 |ig/ml).
Protein accumulation was monitored for three hours after
induction with IPTG (1 mM) and was visualized on a 15% SDS-
polyacrylamide gel with Coomassie Brillant Blue R-250.
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Figure 4.4 Electrospray mass spectrometry results for Recognin Al (12 pmol/|.il)
in 50:50 acetonitrile:water with 0.2% formic acid at an infusion rate of
5 |il/min (35 cone voltage, positive ion scan).
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Figure 4.5 Electrospray mass spectrometry results for Recognin Bl (12 pmol/|a.l)
in 50:50 acetonitrile: water with 0.2% formic acid at an infusion rate of
5 |il/min (50 cone voltage, positive ion scan).
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Figure 4.6 Electrospray mass spectrometry results for Tfl Al 1 hour after protein
initiation. 12 pmol/fil in 50:50 acetonitrile:water with 0.2% formic acid
was injected at a rate of 5 |il/min (35 cone voltage, positive ion mode).
138
100
-I
%
0
8000
8306
\
8320
/
i mass
9000
Figure 4.7 Electrospray mass spectrometry results for Tfl Al 2 hours after protein
initiation. 12 pmol/|il in 50:50 acetonitrile: water with 0.2% formic acid
was injected at a rate of 5 |il/min (35 cone vokage, positive ion mode).
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Figure 4.8 Electrospray mass spectrometry results for Tfl Al 3 hours after protein
initiation. 12 pmol/jil in 50:50 acetonitrile:water with 0.2% formic acid
was injected at a rate of 5 |Lil/min (35 cone voltage, positive ion mode).
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Figure 4.9 Electrospray mass spectrometry results for Tfl Al 4 hours after protein
initiation. 12 pmol/|il in 50:50 acetonitrile:water with 0.2% formic acid
was injected at a rate of 5 |j,l/min (35 cone voltage, positive ion mode).
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Figure 4.10 Electrospray mass spectrometry results for Tfl B 1 1 hour after protein
initiation. 12 pmol/fil in 50:50 acetonitrile:water with 0.2% formic acid
was injected at a rate of 5 jil/min (50 cone voltage, positive ion mode).
142
Figure 4.11 Electrospray mass spectrometry results for Tfl B 1 2 hours after protein
initiation. 12 pmol/|il in 50:50 acetonitrile:water with 0.2% formic acid
was injected at a rate of 5 |il/min (50 cone voltage, positive ion mode).
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Figure 4. 12 Electrospray mass spectrometry results for Tfl B 1 3 hours after protein
initiation. 12 pmol/^il in 50:50 acetonitrile. water with 0.2% formic acid
was injected at a rate of 5 ^il/min (50 cone voltage, positive ion mode).
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Figure 4. 13 Electrospray mass spectrometry results for Tfl Bl 4 hours after protein
initiation. 12 pmol/|il in 50:50 acetonitrile: water with 0.2% formic acid
was injected at a rate of 5 ^il/min (50 cone voltage, positive ion mode).
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Figure 4. 14 Reversed phase high performance liquid chromatograms of (a) HPLC
purified Recognin Al (b) Ni^^ metal affinity purified Recognin Al and (c)
Ni^^ metal affinity purified Tfl Al detected at 210 nm on a CIS-reverse
phase column with H2O (0. 1% TFA): CH3CN (0. 1% TFA) gradient of
100:0 to 50.50 over 60 minutes.
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Figure 4. 15 Reversed phase high performance liquid chromatograms of (a) HPLC
purified Recognin B 1 (b) Ni metal afFmity purified Recognin B 1 and (c)
Ni^' metal affinity purified Tfl B 1 detected at 2 1 0 nm on a Ci 8-reverse
phase column with H2O (0. 1% TFA): CH3CN (0. 1% TFA) gradient of
100:0 to 50:50 over 60 minutes.
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Figure 4.16 Thermal melting profiles of (A) Al and Tfl Al and (B) B 1 and
Tfl Bl monitored with circular dichroism at 222 nm. Spectra were
acquired in 50 mM Na2HP04, 100 mM NaCl, pH 7.4 at protein
concentrations of 3 \iM. Tm was determined as the temperature where
50% of the helix is unfolded.
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APPENDIX
LIST OF AMINO ACIDS
ALIPHATIC
H
H,C
H2N COOH H2n4-
H tl
CH3
COOH
H
CH
COOH
H
,CH3
CH
I
CH2
H2N-|—COOH
H
H3C—CH
H.N-
Glycine (Gly) G
H
Alanine (Ala) A Valine (Val) V Leucine (Leu) L Isoleuci
Ho
^C—CH3
COOH
ne (He)
HYDROXYL OR SULFUR CONTAINING
OH .CH
HoC
H^N-H-COOH
Serine (Ser) S
SH
I
COOH HoN
CH3
ICH—OH
COOH
11
S
I
CHo
I
CH2
H.N- COOHH2N-[-
H "
^
C>'steine (Cys) C Threonine (Thr) T Methionine (Mel ) M
AROMATIC
OH
k
HoC
HoN
CH'
COOH HoN-
H
COOH
Phenylalanine (Phe) F Tyrosine (Tyr) Y
BASIC
N
L//
CH-,
HoN-
NH.
I
^
CHo
I
"
CH.
I
"
CHn
I
H2C
COOH COOH
H
Histidine (His) H
ACIDIC
O.-. .OH
Lysine (Lys) K
o.
r
CH;
HsN-j—
r
OH
COOH
CH2
I
CH2
HoNH—COOH
H H
COOH
Tryptophan (Trp) W
HoN
" \
C=NH
I
NH
I
CH,
I
CH2
I
H2C
HoN- COOH
H
Arginine (Arg) R
O^NH.
CH-
HoN- COOH
H
CYCLIC
H2
c
H2C^ ^CH,
\
HN— COOH
H
Proline (Pro) P
O
NH-,V
CHo
CHo
H2N—^—COOH
H
Aspartic Acid (Asp) D Glutamic Acid (Glu) E Aspiiragine (Asn) N Glutamine (Gin) 0
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